hg_200376.1

Basic information about the TSS

---

TSS ID: hg_200376.1 Species: human Chr: chrX		Start: 120561391 End: 120561415 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000681206.1 Distance: -16 GeneID: 8450 HGNC/MGI_ID: HGNC:2555 UniProt_ID:

Gene_name: cullin 4B Gene_symbol: CUL4B Gene_synonyms: Gene_source: HGNC:2555

TATA-Box annotation

---

Distance to TSS:	140
Nearest PromoterID:	NM_001330624
Entrez ID:	8450
Nearest Unigene:	Hs.102914
Nearest Refseq:	NM_003588
Nearest Ensembl:	ENSG00000158290
Gene Name:	cullin 4B
Gene Alias:	CUL-4B|MRXHF2|MRXS15|MRXSC|SFM2
Gene Description:	cullin 4B
Gene Type:	protein-coding
CpG%:	0.065
GC%:	0.651741
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CUL4B p2@CUL4B p3@CUL4B p4@CUL4B p5@CUL4B p6@CUL4B p7@CUL4B p8@CUL4B p9@CUL4B p10@CUL4B
Sample		p1@CUL4B	p2@CUL4B	p3@CUL4B	p4@CUL4B	p5@CUL4B	p6@CUL4B	p7@CUL4B	p8@CUL4B	p9@CUL4B	p10@CUL4B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	25.91	2.53	2.92	3.31	4.48	3.51	0.58	5.84	2.34	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	20.03	3.24	2.63	2.83	3.84	3.84	0.40	3.84	1.42	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	21.80	1.54	3.67	2.70	4.44	3.09	0.39	4.63	1.16	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	22.66	1.66	2.29	3.95	5.20	4.57	0.21	4.99	1.46	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.15	2.47	2.02	3.15	4.72	3.82	0.90	3.37	0.67	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.54	1.74	2.33	2.33	3.29	2.13	0.58	4.85	2.13	0.97
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	18.30	3.70	3.92	4.14	3.05	4.79	1.09	8.28	1.31	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	21.07	1.70	1.94	2.42	3.63	3.88	0.97	8.48	1.21	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	16.88	1.92	2.99	4.49	3.85	3.85	0.64	6.41	1.07	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.91	2.32	4.06	1.16	4.64	4.64	0.00	2.90	2.32	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.13	0.81	1.62	3.64	3.23	2.83	0.40	4.45	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	12.20	2.44	2.03	3.25	3.25	3.66	0.00	4.07	0.41	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	26.44	21.44	18.21	5.00	1.45	2.42	1.29	0.64	2.26	2.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.75	25.86	18.04	7.37	1.50	3.16	3.31	0.15	2.26	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	21.52	22.61	15.81	5.93	3.95	1.10	4.17	0.66	1.98	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	21.88	25.40	21.38	5.03	2.01	3.27	2.01	0.50	1.26	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	19.22	22.28	19.00	6.12	1.53	2.18	3.28	0.66	1.75	2.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.31	21.51	19.83	8.01	3.37	1.27	0.84	0.84	2.53	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	23.46	30.39	21.86	6.93	0.00	1.07	3.20	0.53	2.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	18.81	23.02	19.71	5.42	2.26	2.11	1.96	0.90	1.05	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.38	17.64	15.10	4.41	0.67	2.94	2.14	0.53	1.20	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.88	20.89	15.88	3.63	2.24	1.90	3.97	0.35	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	17.19	20.55	14.61	4.27	1.16	1.68	2.59	0.13	1.03	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.05	17.23	16.99	4.85	1.94	1.46	1.46	0.73	1.21	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	21.41	21.41	19.09	5.42	1.29	3.10	1.81	0.26	1.55	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.47	17.72	9.18	4.11	1.27	1.58	1.58	0.00	2.85	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.28	28.57	25.82	4.40	3.30	2.75	0.55	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.86	18.86	16.97	6.13	2.59	2.83	2.59	0.24	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	17.44	16.48	12.11	4.20	1.45	2.58	1.13	0.48	1.45	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	21.35	17.55	18.46	6.51	1.99	1.99	1.27	0.36	1.81	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	14.86	14.65	9.00	3.98	1.88	1.47	2.93	0.84	1.88	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.34	17.78	12.90	3.32	2.54	3.13	1.95	0.20	1.76	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.88	20.05	19.41	3.80	1.48	2.32	1.69	0.84	1.06	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	16.49	23.09	15.50	4.62	2.47	2.97	2.97	0.16	1.48	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.51	21.32	18.14	3.93	2.24	2.62	2.43	0.37	1.68	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.20	16.67	15.14	3.45	2.49	1.34	1.72	0.77	1.53	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.74	16.76	16.55	2.86	2.66	1.64	1.64	0.82	1.64	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	12.09	14.10	12.69	4.43	2.42	1.61	2.01	0.00	0.60	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	16.48	16.48	13.24	3.78	2.16	2.16	2.16	0.00	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	14.64	13.20	12.48	3.12	2.64	1.20	1.92	0.72	1.68	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.59	11.06	12.23	3.29	0.94	1.41	1.65	0.24	1.65	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.61	17.13	10.98	3.37	2.34	2.34	1.02	0.29	1.32	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.87	18.14	17.29	3.37	4.01	1.05	0.84	0.42	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.71	12.06	16.78	4.20	2.62	2.62	1.40	0.17	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.26	13.25	15.26	3.61	3.01	1.41	2.21	0.20	1.00	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.05	12.56	10.00	4.19	3.95	1.16	1.16	0.47	1.16	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.23	14.39	17.99	3.36	4.32	1.20	0.48	0.48	1.68	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.82	11.03	7.45	2.38	2.09	2.68	0.89	0.00	1.19	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	13.64	14.12	12.21	4.55	3.11	3.11	0.72	0.24	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	14.15	12.74	12.74	3.03	4.65	1.82	0.81	0.20	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	16.19	12.71	13.94	5.12	4.30	4.30	1.02	0.20	1.23	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	17.12	13.12	14.90	3.34	4.00	2.22	0.67	0.44	1.56	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	41.98	13.99	27.98	69.96	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.58	6.74	12.42	4.61	3.19	1.06	0.71	0.00	1.06	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	5.96	10.60	3.98	3.98	2.32	0.66	0.33	0.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	10.91	9.23	6.71	7.55	6.71	1.68	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.29	11.02	9.64	4.13	1.84	0.92	1.84	0.00	1.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	12.96	10.05	13.94	3.57	1.62	1.94	1.30	0.65	1.30	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	11.24	8.35	10.60	3.53	1.61	1.93	1.28	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	21.69	11.32	13.20	5.66	4.09	2.83	0.63	0.63	2.51	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	6.35	9.87	1.41	0.71	0.00	1.41	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	12.90	4.49	7.85	1.68	1.68	1.12	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	10.35	5.57	3.18	2.39	3.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	20.73	7.81	6.12	3.06	3.40	2.38	0.68	0.00	0.00	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	15.92	8.45	9.10	3.90	3.25	1.62	0.00	0.32	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	5.32	6.74	1.42	1.06	0.00	1.42	0.00	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	7.90	7.90	23.69	7.90	0.00	7.90	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	4.88	4.88	6.83	2.44	3.90	0.98	0.00	0.00	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	10.41	7.44	7.93	4.46	2.98	0.00	0.50	0.00	1.49	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	9.85	5.16	6.57	3.28	2.81	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	25.17	16.23	15.90	5.63	3.64	1.32	0.99	0.00	0.66	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.14	12.37	14.54	4.64	3.71	0.31	2.17	0.00	1.24	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.56	11.62	16.51	3.06	3.67	1.22	0.31	0.61	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	13.94	9.34	9.82	3.80	5.07	0.79	3.48	0.95	0.48	0.95
Adipocyte - breast, donor2	11327-117E4	11.55	2.89	4.81	3.05	1.44	2.73	0.48	0.80	0.96	0.16
Adipocyte - omental, donor1	11473-119C6	16.03	13.87	14.50	3.82	10.43	3.69	5.98	1.65	1.27	0.89
Adipocyte - omental, donor2	11474-119C7	8.22	10.46	5.23	1.49	6.73	2.99	2.99	1.49	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	19.76	6.36	9.04	0.67	5.02	1.34	9.38	1.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	14.04	8.93	8.93	0.00	4.47	1.28	1.91	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	2.20	0.00	1.10	1.10	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	21.23	8.58	5.42	0.00	11.29	0.90	3.61	2.71	1.81	2.26
Adipocyte - subcutaneous, donor3	11408-118E4	11.12	5.21	4.17	1.74	4.69	2.78	1.91	0.35	1.56	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	34.03	9.58	8.41	4.50	9.58	1.76	6.06	0.78	1.96	6.06
Adipocyte differentiation, day04, donor2	13022-139D7	25.48	4.63	3.09	2.32	4.38	1.80	1.54	0.51	1.03	1.29
Adipocyte differentiation, day04, donor3	13025-139E1	24.53	3.07	3.07	1.67	2.79	2.23	0.00	0.28	2.51	1.67
Adipocyte differentiation, day04, donor4	13028-139E4	31.15	5.29	7.64	1.76	4.11	1.76	0.59	0.00	2.94	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	10.70	3.22	4.10	5.39	1.77	5.15	0.88	0.00	1.37	0.97
Adipocyte differentiation, day08, donor2	13023-139D8	31.31	5.49	6.46	3.55	4.20	3.23	0.32	0.00	1.29	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	8.53	8.53	2.13	1.60	1.07	3.20	0.53	0.53	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	0.56	2.23	1.11	0.00	3.90	0.00	0.00	2.23	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	4.57	0.42	1.66	1.25	0.00	4.57	0.00	0.00	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	2.76	2.51	3.27	0.50	1.51	0.75	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	8.51	2.95	1.96	1.96	1.31	2.62	0.65	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	6.09	1.83	1.22	2.13	0.61	5.18	0.00	0.00	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	13.04	8.18	3.54	1.55	5.52	0.66	1.10	3.76	0.22	0.88
Alveolar Epithelial Cells, donor2	11590-120G6	0.72	0.36	1.08	0.36	0.72	0.00	0.36	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	2.40	4.79	1.20	0.00	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	2.52	1.08	1.80	1.98	0.00	1.08	0.18	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	3.35	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	1.64	1.23	2.88	2.05	0.00	0.62	0.21	0.00	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	51.83	171.87	54.24	8.24	92.00	2.52	8.70	79.07	2.29	7.21
Anulus Pulposus Cell, donor2	11463-119B5	44.08	104.58	33.31	2.45	35.51	1.96	3.92	64.17	0.98	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	10.78	3.15	4.94	3.59	2.70	0.90	2.25	0.45	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.99	4.34	4.78	1.30	3.04	0.87	0.87	0.43	2.17	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	2.14	0.00	0.00	0.00	4.28	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	4.48	3.59	5.08	2.39	1.20	1.20	0.60	0.30	1.49	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	3.79	7.59	2.53	3.79	1.26	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	8.58	2.64	4.62	1.32	0.00	0.66	1.32	0.00	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	10.40	1.95	3.57	2.60	2.27	1.30	1.62	0.00	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	7.28	2.43	4.37	2.91	0.97	0.97	2.91	0.00	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	5.34	2.38	2.97	0.59	1.19	2.38	0.59	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.53	2.64	3.77	1.51	0.75	2.64	0.75	0.00	0.75	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	1.45	3.63	3.63	2.90	0.00	0.00	0.73	1.45	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	5.02	2.51	5.02	1.25	2.51	0.00	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.39	4.94	4.12	3.46	3.95	2.31	1.98	0.49	1.32	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	1.36	0.00	4.09	0.00	2.73	1.36	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	7.39	2.71	4.98	2.11	2.87	1.21	1.06	0.30	0.15	0.60
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	9.11	3.75	6.43	2.14	0.54	1.61	0.54	0.54	0.54	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.26	3.02	3.40	1.51	1.89	0.94	1.13	0.38	1.51	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.75	4.54	4.28	1.87	2.14	2.41	1.60	0.27	1.34	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	0.98	3.90	0.00	1.95	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.63	5.14	4.31	1.33	1.82	0.66	1.49	0.17	0.66	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	7.20	9.61	6.00	0.00	1.20	1.20	1.20	0.00	1.20	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	10.62	0.00	0.00	0.00	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	7.38	2.92	3.43	2.06	1.89	1.54	0.86	0.34	1.37	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	9.71	5.34	4.37	2.91	1.94	0.97	3.40	0.97	0.97	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	9.49	4.17	4.17	1.90	3.04	1.14	2.28	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	0.00	7.27	1.21	0.00	1.21	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	11.40	2.85	3.42	3.42	0.57	0.57	0.57	0.57	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.41	2.57	4.92	2.57	1.71	1.28	1.50	0.21	1.92	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	8.78	3.10	3.87	1.55	1.55	1.03	0.52	0.00	1.03	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.32	2.35	2.82	0.94	1.41	1.41	0.94	0.47	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	7.40	2.89	5.14	1.29	1.93	1.29	0.64	0.32	0.64	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	0.00	2.14	1.43	3.57	0.71	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	11.11	2.34	1.75	1.17	0.00	1.75	0.00	0.00	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	9.33	3.31	2.71	0.60	1.51	0.60	1.81	0.60	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	7.13	7.13	1.19	2.38	0.00	0.00	1.19	0.00	0.00	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	8.65	2.03	2.03	1.53	2.54	2.03	4.07	1.02	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	10.19	5.09	4.84	2.80	2.29	1.02	1.02	0.25	1.02	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	11.44	0.64	4.45	1.27	1.27	3.18	0.64	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	5.18	4.75	3.88	1.29	1.73	1.29	1.73	0.00	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.53	3.81	5.08	2.12	1.27	0.64	1.27	0.64	0.85	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	3.19	3.77	2.32	1.74	1.45	2.03	0.00	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	5.67	1.89	1.89	1.89	2.83	0.94	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.97	3.39	2.37	2.54	1.53	1.02	0.68	0.00	0.51	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	6.95	6.95	0.00	2.32	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	2.11	2.11	2.11	4.23	4.23	2.11	4.23	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.51	3.43	3.22	2.14	0.43	0.64	0.86	0.00	1.07	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	6.02	4.81	0.60	1.20	1.20	1.20	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	4.37	3.64	0.73	2.19	2.19	1.46	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.67	4.37	2.99	2.07	1.61	1.84	2.53	0.23	0.46	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	5.10	10.20	0.00	0.00	2.55	0.00	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	5.08	4.58	4.07	2.80	5.08	1.02	1.02	0.25	0.76	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.81	3.10	3.72	1.03	1.45	1.03	1.24	0.41	2.06	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.73	4.90	4.28	0.92	1.53	1.84	0.31	0.00	0.92	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.99	1.91	1.91	2.87	1.43	1.91	0.48	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	9.98	2.22	3.55	2.00	1.11	1.55	0.44	0.00	0.67	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	4.58	3.05	3.05	1.53	1.53	1.53	1.53	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	5.54	4.43	2.22	1.11	2.22	0.55	0.00	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	5.83	2.91	2.91	2.12	1.06	1.32	0.26	0.00	0.26	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	6.91	3.63	4.00	0.73	1.82	2.18	0.73	0.00	1.82	0.00
Astrocyte - cerebellum, donor1	11500-119F6	9.95	6.63	5.16	2.70	2.58	1.97	0.61	0.49	0.37	0.74
Astrocyte - cerebellum, donor2	11580-120F5	15.23	3.94	4.11	0.51	1.88	0.86	0.34	0.17	0.86	0.34
Astrocyte - cerebellum, donor3	11661-122F5	3.15	1.26	0.42	0.21	0.00	0.42	0.21	0.00	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	10.81	1.74	1.05	6.62	0.00	2.44	1.05	0.00	2.44	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	11.00	3.56	5.34	5.99	1.29	1.94	0.16	0.16	1.62	1.94
Astrocyte - cerebral cortex, donor3	11392-118C6	11.49	1.94	2.39	4.47	1.34	1.64	0.30	0.15	1.19	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	16.17	2.87	1.95	8.60	1.26	12.27	2.06	0.57	2.52	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	15.66	1.75	1.75	7.02	0.38	15.66	1.50	0.13	3.13	1.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.44	2.73	1.59	7.06	2.28	18.44	1.25	0.46	3.19	1.37
Basophils, donor1	12241-129G9	6.02	0.26	0.78	2.62	0.00	2.88	0.00	0.00	1.05	0.00
Basophils, donor2	12242-129H1	20.57	3.25	1.80	6.86	1.80	4.33	0.72	0.00	1.08	0.36
Basophils, donor3	12243-129H2	7.79	0.88	1.03	3.23	0.59	2.50	0.15	0.00	0.88	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	1.51	0.43	0.00	0.22	0.00	0.65	0.00	0.00	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	1.37	1.37	0.91	0.91	0.00	0.00	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	1.88	0.63	1.26	1.88	0.00	0.00	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	1.25	0.42	0.42	0.62	0.00	0.21	0.00	0.00	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	1.38	1.15	1.61	1.61	0.00	0.23	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	4.14	3.06	4.86	4.86	0.00	0.72	1.44	0.18	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	16.90	2.89	2.58	6.70	1.85	1.34	3.19	0.72	0.93	1.44
Burkitt's lymphoma cell line:RAJI	10476-106I8	11.41	0.93	1.16	9.08	1.16	5.12	7.92	0.00	0.93	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	9.27	4.48	4.48	6.72	0.00	2.56	0.00	0.00	1.92	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	0.00	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.76	1.13	1.13	3.38	1.13	2.25	1.13	0.56	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	7.61	0.37	1.11	4.27	0.19	2.78	0.00	0.00	0.37	0.37
CD14+ Monocytes, donor3	11381-118B4	8.78	0.22	0.66	2.20	0.22	2.20	0.44	0.00	0.44	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	22.93	2.26	3.96	10.19	0.85	1.13	1.42	0.28	1.70	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	19.71	1.90	4.17	6.07	0.38	3.41	0.76	0.38	2.65	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	24.66	2.96	7.89	5.92	0.33	1.97	1.64	0.00	2.96	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	8.96	1.16	1.45	4.19	0.14	2.31	0.00	0.14	1.01	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	10.86	0.30	1.21	3.32	0.00	2.41	0.00	0.00	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	15.87	0.71	0.71	4.26	0.24	3.55	0.00	0.00	0.95	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.85	0.50	1.00	3.35	0.00	1.84	0.00	0.00	0.33	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.18	0.28	0.55	2.76	0.00	3.31	0.00	0.00	0.55	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.46	0.00	0.50	1.98	0.00	2.23	0.00	0.00	0.74	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5.09	0.59	0.20	1.76	0.00	2.55	0.00	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3.92	0.00	0.71	2.67	0.18	0.89	0.00	0.00	0.89	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.92	0.44	0.65	3.26	0.00	2.39	0.00	0.22	0.87	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	1.40	0.47	0.70	1.87	0.00	1.64	0.00	0.00	0.47	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	1.58	1.06	0.53	0.00	1.58	0.00	0.00	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	0.00	0.00	1.11	0.00	1.11	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.87	0.74	0.74	4.61	0.15	2.83	0.00	0.00	0.59	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	6.59	0.80	0.40	2.00	0.00	2.20	0.00	0.00	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	4.79	0.00	0.83	3.12	0.00	4.37	0.00	0.21	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	4.12	0.69	0.23	3.20	0.46	2.52	0.00	0.00	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	5.20	0.23	0.23	1.81	0.00	2.04	0.00	0.00	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	4.80	0.00	0.00	1.31	0.44	2.18	0.00	0.00	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.99	1.08	1.08	4.03	0.27	3.23	0.27	0.00	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.20	0.52	1.22	3.66	0.17	2.09	0.00	0.00	0.70	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.73	0.00	1.26	4.21	0.42	5.05	0.00	0.42	0.84	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	0.18	0.37	2.20	0.00	1.47	0.00	0.00	0.18	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	5.64	0.00	0.35	0.70	0.35	2.11	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	0.00	0.00	1.75	0.00	3.07	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	0.17	0.70	3.31	0.17	1.57	0.00	0.17	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.95	0.37	0.00	2.23	0.00	1.12	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	6.68	0.86	1.08	3.66	0.22	2.16	0.00	0.00	0.43	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.09	1.64	2.46	3.28	0.00	2.46	0.00	0.41	0.82	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	0.70	0.46	1.62	0.00	1.85	0.00	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	4.41	0.23	0.23	1.39	0.23	2.09	0.00	0.00	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	5.45	0.00	0.22	5.67	0.65	2.18	0.00	0.00	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	5.31	0.00	0.69	6.24	0.00	2.54	0.00	0.00	0.69	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	5.63	0.22	0.43	4.77	0.00	2.17	0.00	0.00	0.43	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	9.34	1.25	1.25	8.56	0.47	4.36	0.00	0.00	1.56	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	10.30	0.70	0.70	7.16	0.17	2.45	0.00	0.17	0.52	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	26.09	1.56	1.78	6.91	0.45	7.80	0.22	0.00	2.01	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	2.55	0.26	0.77	6.12	0.26	3.57	0.26	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	5.93	0.44	0.44	6.81	0.00	3.95	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	4.42	0.00	0.00	6.11	0.00	3.16	0.00	0.21	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	22.36	0.00	8.13	6.10	2.03	8.13	4.06	0.00	4.06	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	18.98	2.03	1.36	4.07	0.68	6.78	3.39	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	2.07	3.11	7.25	4.14	4.14	2.07	0.00	2.07	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	15.99	2.67	4.26	6.40	3.20	6.40	2.13	0.00	2.67	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	14.47	2.14	3.75	8.58	3.22	7.50	3.75	0.00	2.14	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	18.25	0.70	2.11	5.62	2.81	4.21	1.40	0.00	2.11	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	15.69	2.35	2.35	7.06	3.14	4.71	2.35	0.00	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	1.32	5.27	5.27	2.64	5.27	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	33.70	4.11	2.47	1.64	1.64	9.86	2.47	0.00	3.29	0.82
CD19+ B Cells, donor2	11624-122B4	19.59	2.90	4.35	0.73	1.45	7.25	0.00	0.73	4.35	2.18
CD19+ B Cells, donor3	11705-123B4	29.28	1.01	4.04	5.05	0.50	8.08	0.50	0.00	3.53	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.85	0.00	0.81	8.89	0.81	10.51	0.81	0.40	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.80	0.80	1.60	5.59	1.60	5.19	0.00	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	9.04	2.01	3.01	5.02	0.00	2.01	0.00	0.00	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	8.99	1.12	2.81	2.25	0.00	2.25	0.00	0.00	1.69	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	7.89	1.13	3.38	9.02	0.38	1.88	1.13	0.00	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	13.98	2.93	3.83	9.02	0.23	3.83	0.90	0.23	1.35	0.23
CD4+ T Cells, donor1	11225-116C1	38.21	6.43	7.14	3.93	2.50	3.21	0.00	1.07	2.50	5.00
CD4+ T Cells, donor2	11306-117C1	25.11	0.61	2.45	2.45	0.00	2.45	0.00	0.00	1.22	1.22
CD4+ T Cells, donor3	11382-118B5	28.97	2.13	1.52	4.57	0.61	1.22	1.83	0.30	0.91	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	39.05	3.57	7.66	4.85	10.98	1.53	5.87	0.26	2.30	3.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	39.30	3.37	9.21	5.39	10.78	1.80	7.19	0.45	2.25	3.37
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	41.97	4.31	10.35	4.60	9.77	2.59	5.17	0.29	1.44	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.81	3.32	5.69	2.84	3.79	3.32	1.42	0.47	2.84	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	23.18	2.81	4.92	7.02	2.11	0.70	2.11	1.40	0.00	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	46.15	3.30	6.59	0.00	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.06	1.59	3.47	6.21	2.89	0.72	2.89	0.29	1.73	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	28.47	2.20	5.08	4.41	4.58	0.85	1.86	0.17	1.53	1.19
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	26.60	1.45	5.00	4.19	5.16	2.42	2.26	0.00	2.42	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.55	1.79	2.24	6.72	4.03	1.79	2.69	0.00	2.24	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	20.61	0.70	5.94	4.89	5.59	1.05	0.70	0.35	2.10	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	36.52	2.20	2.64	2.64	9.24	3.08	3.96	0.44	3.96	3.52
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	29.51	3.37	2.53	5.06	3.79	0.00	3.37	0.42	0.84	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.97	2.91	4.16	4.36	2.91	0.62	2.91	0.00	1.04	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.37	2.00	3.01	3.68	2.00	1.00	0.67	0.67	1.34	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	26.92	7.34	9.79	2.99	4.62	2.18	1.63	1.09	0.82	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	50.38	9.11	12.33	6.43	4.82	0.00	3.75	1.07	2.68	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	39.45	3.59	7.17	3.59	7.17	1.79	0.00	0.00	1.79	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	24.11	2.04	2.60	8.16	5.38	3.52	5.01	0.00	1.11	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.45	2.38	2.82	4.33	2.17	0.43	5.63	0.43	0.87	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	24.38	1.68	3.78	4.20	4.62	0.42	2.94	0.42	1.26	2.52
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	3.03	3.03	7.58	3.54	1.01	2.02	1.01	1.01	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	18.20	2.17	2.17	3.90	3.90	0.87	3.03	0.87	0.00	1.30
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	36.17	3.49	6.54	3.92	7.84	1.74	4.79	0.00	0.44	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	29.20	5.44	6.43	6.93	5.94	1.98	6.43	0.00	1.98	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	23.08	2.77	2.77	5.54	2.77	1.85	0.00	0.00	1.85	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	0.00	9.77	1.40	2.79	0.00	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	34.62	4.15	5.26	6.37	6.92	3.05	3.32	0.83	1.38	1.38
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	38.53	5.15	7.36	3.93	8.10	2.70	3.44	0.98	0.98	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	7.70	4.62	10.78	3.08	1.54	6.16	0.00	3.08	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	35.45	2.86	6.80	3.58	4.66	3.58	4.66	0.36	1.43	2.15
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	29.08	4.15	2.77	2.77	12.46	2.77	2.77	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	27.83	1.96	4.58	3.27	2.29	3.27	1.31	0.00	1.64	2.95
CD8+ T Cells, donor2	11307-117C2	20.65	0.38	3.38	1.50	1.13	2.25	0.38	0.38	1.13	0.38
CD8+ T Cells, donor3	11383-118B6	26.26	1.77	5.05	2.27	2.78	2.27	0.50	0.25	1.01	4.04
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	3.21	0.23	0.69	3.44	0.69	2.52	0.23	0.00	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.59	0.00	0.00	2.16	0.96	2.40	0.00	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	4.10	0.00	0.27	2.46	2.74	1.37	0.00	0.00	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	7.51	0.00	0.30	4.80	2.70	2.40	0.00	0.00	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	4.80	0.24	0.48	2.16	0.48	2.16	0.24	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.91	0.45	0.23	2.05	0.91	2.05	0.45	0.00	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	5.65	0.22	0.22	0.87	1.52	1.96	0.00	0.22	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	4.47	0.26	0.26	1.84	0.79	2.11	0.00	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	4.46	0.00	0.23	1.88	2.35	2.58	0.00	0.00	0.47	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	5.13	0.00	0.30	0.60	2.11	2.72	0.00	0.30	0.30	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	8.13	0.00	0.29	1.16	2.03	2.61	0.00	0.00	0.58	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.12	0.27	0.80	1.87	1.33	1.33	0.00	0.00	0.80	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.94	1.31	1.75	0.44	2.19	2.19	0.88	0.00	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	0.91	0.46	2.28	2.73	0.91	1.37	0.00	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	2.24	4.48	2.24	2.24	4.48	1.49	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	6.84	0.36	0.36	2.16	2.16	0.36	0.36	0.00	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	9.21	0.00	0.58	1.44	1.73	1.44	0.29	0.00	0.58	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	5.19	0.24	0.71	0.94	1.41	0.47	0.00	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.80	0.00	0.63	2.85	1.27	4.12	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	5.54	0.62	0.62	0.92	1.23	1.23	0.00	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.17	0.96	0.00	1.60	1.28	2.56	0.00	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.50	1.53	0.76	2.29	1.53	2.68	0.38	0.00	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	10.25	0.79	0.00	1.18	1.58	1.58	0.00	0.00	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	0.00	0.00	1.51	0.00	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	22.48	8.83	3.21	3.21	3.21	4.01	1.61	0.00	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	19.58	2.10	2.80	2.10	1.40	6.29	3.50	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	28.05	2.00	1.00	4.01	4.01	1.00	3.01	2.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	27.42	58.49	40.21	3.66	3.66	1.83	10.97	1.83	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	33.60	35.08	17.29	4.94	19.76	0.49	21.25	6.92	1.48	4.45
Cardiac Myocyte, donor3	11686-122I3	7.79	7.47	4.53	4.21	3.79	0.74	1.89	1.26	1.05	1.05
Chondrocyte - de diff, donor1	11261-116G1	82.16	41.60	26.00	3.12	58.24	1.04	24.61	11.44	1.73	4.51
Chondrocyte - de diff, donor2	11338-117F6	23.81	33.41	12.08	0.71	27.36	0.36	17.41	9.24	1.42	5.69
Chondrocyte - de diff, donor3	11410-118E6	29.01	27.88	15.59	2.96	28.10	1.25	15.36	8.08	1.82	3.53
Chondrocyte - re diff, donor2	11339-117F7	5.37	1.79	6.27	2.69	2.69	0.90	0.90	0.00	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	8.90	8.49	5.66	1.62	3.64	2.02	1.21	1.21	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	19.05	12.16	10.21	10.79	3.44	2.75	8.03	0.80	1.26	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	7.48	9.83	5.34	3.42	2.78	5.99	0.00	1.92	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	15.40	8.41	7.79	6.02	3.63	2.21	5.31	0.35	1.24	3.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.09	9.63	9.72	4.59	1.19	5.32	2.93	0.64	1.28	1.19
Corneal Epithelial Cells, donor1	11526-119I5	0.66	0.44	0.22	0.66	0.22	0.44	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	2.28	1.14	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	1.79	0.51	0.77	1.02	0.00	1.28	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.95	0.33	0.83	3.14	0.66	6.44	0.33	0.00	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	3.15	0.32	0.00	3.47	0.32	8.20	0.00	0.00	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	0.00	0.00	3.45	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	4.54	0.43	0.54	2.38	0.54	4.32	0.11	0.00	1.19	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.23	2.73	6.83	6.15	3.07	4.10	7.17	0.34	2.05	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	7.18	1.96	5.22	6.53	3.26	9.14	0.00	1.96	1.96
Dendritic Cells - plasmacytoid, donor3	11385-118B8	18.87	2.90	6.29	3.87	2.42	4.36	9.19	0.00	0.48	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	12.17	7.84	4.34	1.83	2.67	0.33	2.00	0.00	0.00	1.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	4.11	2.93	2.35	2.35	0.00	1.76	1.17	0.00	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	14.14	2.83	2.83	1.70	1.13	1.41	0.85	0.28	0.57	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	9.04	3.93	1.57	3.15	1.57	0.39	0.79	1.57	0.79
Endothelial Cells - Artery, donor1	11264-116G4	14.25	4.07	3.20	0.87	2.62	1.16	1.45	0.29	0.87	1.75
Endothelial Cells - Artery, donor2	11341-117F9	19.29	9.41	4.94	1.88	4.00	1.88	3.29	0.24	1.18	1.41
Endothelial Cells - Artery, donor3	11413-118E9	14.73	5.26	3.16	4.21	3.86	0.88	1.93	0.70	1.75	4.03
Endothelial Cells - Lymphatic, donor1	11236-116D3	21.72	11.30	11.97	5.10	10.64	0.89	22.61	0.22	1.33	4.43
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.78	18.26	13.69	6.39	12.47	1.22	30.73	2.13	2.74	7.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	27.63	12.12	9.87	3.10	6.20	1.13	12.40	0.00	3.38	4.51
Endothelial Cells - Microvascular, donor1	11265-116G5	5.65	8.62	9.51	1.19	0.00	1.49	0.59	0.00	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	7.81	2.60	2.60	0.52	0.52	1.56	0.52	0.52	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	2.55	2.13	3.26	1.42	0.43	1.28	0.14	0.00	0.57	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	20.81	16.00	8.80	1.60	7.20	2.00	7.20	2.00	1.60	1.20
Endothelial Cells - Thoracic, donor2	11343-117G2	7.86	1.57	1.05	1.05	1.57	0.00	1.57	0.52	1.05	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.81	36.90	21.12	13.54	16.77	3.23	12.67	2.24	4.60	8.32
Endothelial Cells - Umbilical vein, donor2	11324-117E1	72.13	37.80	20.86	6.52	8.04	1.74	1.96	1.52	6.08	6.08
Endothelial Cells - Umbilical vein, donor3	11400-118D5	85.86	22.72	11.48	5.74	9.04	2.81	2.20	1.59	5.62	8.67
Endothelial Cells - Vein, donor1	11267-116G7	11.38	9.10	2.28	1.14	2.28	0.00	1.14	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	13.97	10.48	4.89	0.70	1.40	1.40	4.89	1.40	0.00	2.79
Endothelial Cells - Vein, donor3	11416-118F3	13.35	4.55	4.08	2.98	2.36	0.94	1.73	0.47	2.20	1.73
Eosinophils, donor1	12244-129H3	15.25	0.00	0.00	30.49	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	90.76	11.55	11.55	13.20	3.30	3.30	0.00	0.00	4.95	8.25
Eosinophils, donor3	12246-129H5	42.80	0.00	7.13	3.57	0.00	3.57	0.00	0.00	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	1.22	0.24	1.47	0.49	0.00	0.49	0.00	0.00	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	18.88	6.98	8.62	2.46	2.87	1.64	0.82	0.00	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.17	5.26	6.35	1.31	2.52	1.09	1.31	1.42	0.77	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.76	6.39	6.50	2.38	0.65	1.95	0.00	0.33	1.19	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	7.16	4.61	2.79	5.22	1.58	1.46	1.09	0.85	1.09	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	25.25	11.74	5.32	5.87	23.34	2.73	11.05	6.41	3.00	3.68
Fibroblast - Aortic Adventitial, donor2	11326-117E3	10.65	4.75	4.96	2.00	2.00	1.69	0.53	0.11	0.84	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	15.55	8.43	3.69	4.22	2.11	2.37	1.58	0.53	0.79	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	17.94	4.65	6.31	2.66	2.99	2.99	1.66	0.33	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	10.89	7.71	4.99	1.36	4.54	2.27	1.81	0.45	0.45	0.91
Fibroblast - Cardiac, donor2	11345-117G4	5.31	2.27	3.03	0.00	3.03	0.00	0.76	0.00	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	6.94	2.84	2.68	1.89	3.15	0.63	1.73	0.47	0.16	0.95
Fibroblast - Cardiac, donor4	11452-119A3	30.92	18.79	17.58	7.58	19.10	2.73	6.97	1.52	3.33	7.58
Fibroblast - Cardiac, donor5	11456-119A7	21.83	15.36	7.36	2.66	6.22	0.63	5.71	1.02	0.89	1.90
Fibroblast - Cardiac, donor6	11460-119B2	27.44	20.77	12.13	2.88	12.43	1.06	8.03	4.40	0.76	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.06	4.96	4.56	2.14	2.14	2.55	3.08	0.00	0.80	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.14	6.47	9.92	5.61	3.02	3.45	4.31	0.43	0.43	2.16
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	58.59	16.11	5.86	45.41	2.93	17.58	10.25	4.39	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	6.46	2.08	1.15	2.54	0.69	1.85	0.00	0.00	0.46	0.46
Fibroblast - Conjunctival, donor3	11692-122I9	15.09	16.79	10.35	10.69	2.04	1.87	0.68	0.00	1.53	1.36
Fibroblast - Dermal, donor1	11269-116G9	32.40	6.34	7.28	1.64	8.69	1.88	0.94	3.29	1.88	3.52
Fibroblast - Dermal, donor2	11346-117G5	15.57	1.42	4.72	1.89	3.77	0.47	0.00	0.94	1.42	0.94
Fibroblast - Dermal, donor3	11418-118F5	24.66	8.34	7.62	3.14	16.08	1.09	1.81	5.68	2.30	3.14
Fibroblast - Dermal, donor4	11450-119A1	12.10	4.75	5.31	3.96	0.79	1.81	0.34	0.34	0.45	0.68
Fibroblast - Dermal, donor5	11454-119A5	17.45	4.54	2.27	5.06	0.87	1.92	0.17	0.35	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	15.27	5.36	3.41	3.90	0.81	2.11	0.81	0.16	0.65	1.46
Fibroblast - Gingival, donor1	11237-116D4	49.14	42.90	22.28	7.08	42.69	2.08	4.79	8.95	3.12	9.79
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	36.94	18.34	13.10	4.19	12.84	3.41	1.83	1.05	2.62	1.05
Fibroblast - Gingival, donor2	11318-117D4	11.60	6.98	5.53	4.48	3.56	1.19	0.66	0.53	1.98	1.58
Fibroblast - Gingival, donor3	11394-118C8	42.54	23.88	13.44	8.90	11.51	2.80	1.26	2.71	2.80	4.06
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	14.54	17.66	9.35	23.89	1.04	3.12	4.16	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.15	9.69	7.05	2.64	9.34	1.41	0.00	0.53	1.06	2.29
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	30.87	9.51	6.24	7.02	10.60	3.27	0.94	0.62	1.40	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.96	7.71	7.71	5.27	9.33	3.11	0.54	0.14	1.35	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	69.87	6.00	7.76	1.76	1.06	10.23	0.35	0.00	6.35	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	35.24	8.77	8.77	4.39	9.36	4.09	0.29	1.02	3.07	1.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	29.04	8.18	7.50	5.86	7.91	3.27	0.27	0.41	1.64	1.36
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.27	8.23	7.90	5.16	5.59	2.41	0.22	0.11	1.43	2.19
Fibroblast - Gingival, donor9 (control)	11927-125I1	34.78	7.04	8.95	4.11	2.64	3.52	0.29	0.44	3.52	1.17
Fibroblast - Lung, donor1	11270-116H1	6.80	2.72	2.72	0.00	1.36	1.36	1.36	0.00	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	10.45	10.45	7.46	7.46	4.48	5.97	2.98	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	10.34	3.17	1.69	3.80	1.90	2.11	0.63	0.21	0.42	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	18.33	11.66	2.50	0.00	5.00	3.33	0.83	0.00	0.83	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	4.20	2.80	0.00	2.80	1.40	0.00	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	2.24	0.84	0.00	0.28	0.28	0.00	0.00	1.12	0.28
Fibroblast - Mammary, donor1	11540-120B1	15.83	1.22	2.03	2.44	2.44	1.22	0.00	0.41	0.81	2.44
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	5.96	5.96	0.00	5.96	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	15.71	13.19	7.95	7.76	7.56	2.52	1.16	1.16	0.78	2.52
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.82	14.26	7.43	6.83	5.76	4.25	0.61	1.37	1.82	4.25
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.63	24.17	13.16	9.79	22.64	3.67	2.75	3.67	4.28	9.79
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	37.40	9.16	4.96	1.14	4.58	1.14	0.00	0.00	2.67	1.91
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	14.04	5.40	3.78	2.43	4.59	2.97	0.27	0.00	1.89	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	39.66	7.31	5.57	2.67	10.32	1.39	0.58	2.20	2.32	3.25
Fibroblast - Pulmonary Artery, donor1	11250-116E8	16.58	13.26	7.52	5.42	12.93	1.22	9.62	2.87	0.88	2.43
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	30.88	9.14	6.30	1.42	11.79	1.22	0.61	3.86	1.63	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.67	2.67	1.34	2.00	0.67	1.34	0.00	0.00	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.23	6.72	5.14	3.95	4.35	1.98	0.79	0.00	2.77	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	36.51	15.68	10.52	6.95	25.40	2.78	8.53	5.75	1.98	1.39
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.12	30.02	13.68	2.84	39.79	0.89	21.31	6.75	2.49	3.55
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	31.93	22.07	14.19	2.96	39.81	1.18	16.75	8.28	1.58	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	36.70	15.95	8.72	3.61	27.38	4.51	5.42	6.92	1.81	3.01
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.56	34.22	20.08	3.45	39.94	3.45	15.65	8.42	1.40	2.59
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	48.84	22.27	9.11	5.31	48.59	2.28	23.79	11.89	3.29	3.29
Fibroblast - skin normal, donor1	11553-120C5	36.75	16.90	12.31	1.97	25.27	1.97	9.68	2.46	1.31	3.61
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	33.28	13.43	9.22	10.43	33.69	4.01	8.42	5.81	2.41	5.01
Fibroblast - skin normal, donor2	11561-120D4	22.60	17.48	13.16	3.92	23.51	2.41	7.53	6.23	1.31	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	58.33	32.34	13.60	6.95	73.14	3.32	20.55	25.09	2.72	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	41.51	42.67	25.10	4.89	53.19	2.07	20.55	10.11	2.98	3.73
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	32.65	30.94	26.33	3.25	18.98	3.08	19.66	4.27	0.68	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	50.91	18.39	12.48	3.28	39.41	2.96	12.48	8.87	0.66	2.63
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	23.75	13.53	12.14	4.26	20.03	1.17	7.88	2.77	0.85	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	20.58	11.64	6.41	2.19	17.21	0.84	3.54	3.20	1.01	2.87
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.38	15.68	12.86	4.55	11.13	1.73	5.33	0.94	1.73	1.41
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	66.48	44.32	22.16	66.48	0.00	66.48	22.16	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	3.49	8.72	6.10	0.00	6.10	0.00	0.00	3.49	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	7.28	2.25	2.25	4.16	0.35	2.43	0.87	0.00	1.39	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	4.42	3.12	2.08	4.68	0.26	2.08	0.00	0.00	1.04	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	7.15	2.30	3.32	5.62	0.77	2.56	1.53	0.00	1.28	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	6.89	4.59	4.59	4.59	0.00	1.53	0.00	0.00	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	5.10	7.66	7.66	2.55	0.00	1.28	0.00	0.00	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	10.55	18.26	15.40	11.13	0.86	4.28	2.00	0.57	2.28	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	18.75	34.47	29.51	9.93	1.10	2.48	4.69	0.55	2.76	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.05	20.32	14.84	7.76	0.91	4.11	2.05	0.23	2.28	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	11.10	16.05	13.87	4.76	0.79	4.16	1.98	0.40	1.19	2.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	14.01	41.50	29.08	14.80	0.53	1.85	6.34	0.53	2.64	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	13.05	16.63	13.05	5.54	0.33	1.63	3.59	0.00	1.96	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	12.38	13.27	8.84	5.31	0.88	3.10	1.33	0.88	1.77	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	4.10	12.01	10.32	4.24	1.27	2.40	2.83	0.71	0.57	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.28	8.99	8.13	3.57	0.49	3.08	2.34	0.99	0.62	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	5.10	9.40	5.37	5.91	0.54	2.15	2.42	0.27	1.07	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	4.58	4.96	5.58	3.59	0.12	1.61	2.97	0.12	0.50	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	6.64	6.37	5.68	3.74	0.14	1.52	1.25	0.28	0.28	0.83
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.08	10.37	6.91	3.86	0.61	1.63	2.24	0.41	0.41	1.02
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	5.70	12.09	12.32	4.56	0.23	1.83	3.19	0.00	0.46	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	2.87	9.22	9.72	3.86	0.62	1.62	2.37	0.12	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	4.81	16.83	11.80	5.46	0.66	1.53	1.31	0.00	1.09	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.68	14.18	9.16	4.73	0.59	1.77	2.07	0.00	1.18	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	5.88	9.22	7.47	4.77	0.64	0.95	2.70	0.00	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	5.14	12.06	10.50	5.14	0.67	0.89	2.90	0.00	0.67	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	10.28	8.07	9.28	3.23	0.20	3.02	1.81	0.00	1.41	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	9.33	5.09	6.28	4.24	0.85	2.71	2.04	0.17	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	8.51	19.42	13.92	6.47	1.42	2.48	4.88	0.53	0.80	0.80
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	11.45	21.23	14.05	8.32	0.10	6.24	2.39	0.21	1.77	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	15.37	16.57	13.49	5.81	1.20	5.12	2.90	0.00	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	9.96	6.86	7.08	2.66	0.33	2.10	1.66	0.11	1.22	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	8.82	15.89	11.73	6.32	0.92	1.58	3.41	0.17	0.67	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	7.55	11.43	10.00	4.70	1.23	1.84	4.49	0.20	0.82	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	9.90	11.97	12.38	5.78	0.41	2.68	2.27	0.00	1.44	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	8.53	9.92	7.61	5.19	0.23	2.42	1.61	0.23	0.81	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	7.84	7.67	6.34	4.00	0.17	2.50	2.17	0.00	0.33	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.77	10.80	7.94	4.85	0.00	5.29	0.66	0.00	2.20	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	11.68	8.73	8.73	4.43	0.86	2.21	1.97	0.37	1.11	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.43	5.84	5.84	4.86	0.16	3.24	1.62	0.16	1.46	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	15.07	13.15	10.90	7.06	0.00	5.45	1.60	0.00	1.60	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	8.91	5.31	4.07	3.03	0.47	1.23	0.66	0.00	0.47	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.81	4.43	4.75	4.43	0.32	1.58	0.79	0.00	0.79	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.20	10.34	6.69	4.87	0.91	4.26	1.52	0.00	1.52	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.77	4.60	4.29	3.35	0.52	2.51	0.63	0.10	1.15	1.15
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	12.95	8.12	6.59	3.95	0.00	1.98	1.32	0.22	1.10	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	16.83	6.45	6.17	3.65	0.00	3.37	0.28	0.28	2.24	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	12.13	1.76	2.59	3.06	0.19	1.30	0.28	0.00	0.74	1.02
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.16	5.62	6.15	3.21	1.07	1.07	0.53	0.27	2.41	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	13.16	3.98	2.30	2.60	0.15	1.84	0.61	0.00	1.53	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	11.53	1.68	1.94	1.17	0.78	1.55	0.78	0.00	0.52	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	13.28	3.80	2.98	2.44	0.27	1.90	0.81	0.27	1.36	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.22	5.71	5.53	3.32	0.74	1.11	0.74	0.18	1.11	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	9.43	6.80	4.61	1.75	0.66	3.07	1.10	0.44	1.97	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	46.61	10.91	13.88	4.96	0.00	5.95	2.98	0.00	3.97	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.00	5.80	4.62	1.98	1.85	3.03	0.40	0.00	0.53	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	11.70	3.83	2.82	1.82	1.01	1.41	0.40	0.20	0.61	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	26.94	19.32	21.10	6.86	0.51	8.90	0.51	0.25	2.80	5.59
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	7.37	23.69	15.73	5.57	0.80	5.77	5.57	0.00	0.60	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.24	10.01	9.24	5.55	0.46	2.93	2.47	0.15	0.77	0.92
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	4.71	12.27	12.07	6.75	0.61	1.84	2.25	0.00	0.41	1.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	3.13	11.58	6.88	4.07	0.94	2.19	1.88	0.00	0.63	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	2.83	12.71	10.45	6.50	0.57	1.70	2.83	0.00	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	6.92	16.14	16.14	6.46	0.92	0.00	4.15	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	7.42	17.32	7.42	0.00	7.42	2.47	2.47	0.00	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	10.44	15.86	15.09	11.99	1.93	4.64	2.71	0.39	0.77	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	25.67	11.23	4.81	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	12.17	26.08	12.17	3.48	0.00	0.00	0.00	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.86	16.60	16.27	11.72	1.63	3.91	1.95	0.00	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.77	19.35	20.59	10.71	0.82	4.12	4.94	0.82	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	10.00	23.33	3.33	0.00	0.00	3.33	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	8.39	15.94	20.41	11.47	0.84	5.31	3.36	0.00	0.56	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	7.52	17.98	13.40	14.38	1.31	5.88	3.60	0.00	1.31	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	5.87	19.29	24.33	12.58	0.00	1.68	0.00	0.00	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.18	20.36	13.36	9.86	1.91	6.36	2.86	0.00	1.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	7.81	18.00	14.61	8.83	1.02	3.74	2.04	0.00	0.68	2.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	8.35	27.15	18.79	16.71	2.09	4.18	2.09	0.00	4.18	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	10.31	24.63	18.90	10.31	0.57	8.02	4.01	0.00	0.57	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	5.33	15.69	14.80	6.22	0.30	3.26	1.18	0.00	0.59	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	8.47	11.86	15.25	15.25	1.69	0.00	3.39	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	11.60	14.08	19.05	15.33	1.66	4.14	3.31	0.00	0.41	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	17.26	17.03	9.21	1.38	5.29	3.22	0.69	1.38	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	21.07	5.27	0.00	0.00	0.00	15.81	0.00	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.30	14.99	18.84	11.15	1.92	2.31	5.38	0.77	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	9.13	20.86	18.91	11.41	0.65	2.93	6.19	0.00	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.03	20.07	14.71	7.36	0.67	0.67	5.35	0.67	1.34	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.56	28.90	27.35	11.94	0.77	6.93	4.62	0.00	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	9.24	22.59	17.80	8.22	1.71	5.82	4.45	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	14.91	44.73	14.91	14.91	2.48	2.48	14.91	0.00	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	35.86	31.61	15.10	0.47	5.66	3.30	0.47	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	9.05	20.52	26.55	10.86	1.21	6.03	5.43	0.00	1.21	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.72	29.50	20.35	5.60	0.51	5.60	3.56	0.51	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	11.57	26.32	20.74	14.36	0.80	4.79	6.38	0.40	0.40	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	10.36	34.53	23.68	11.35	1.97	4.44	8.39	0.99	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	8.26	38.95	25.97	10.62	1.18	8.26	8.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	5.25	29.17	18.67	8.75	1.17	2.33	3.50	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.09	32.92	21.51	7.46	0.44	7.02	6.14	0.00	1.32	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	12.72	21.19	11.87	5.09	0.85	3.39	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	11.34	14.92	7.16	2.98	0.60	4.18	2.98	0.60	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	10.68	20.38	15.53	5.82	0.97	2.43	4.37	0.00	0.97	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	13.70	2.28	1.14	1.14	4.57	0.00	3.42	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	10.81	2.49	3.33	1.66	6.65	0.42	1.25	0.00	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	5.62	5.62	3.37	0.00	5.62	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	45.35	19.03	15.22	4.44	21.25	2.85	0.63	1.59	1.27	3.81
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	22.56	8.35	9.19	1.67	7.52	2.51	0.42	0.42	0.42	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	5.92	3.71	3.60	4.41	0.46	4.29	1.86	0.46	1.28	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	9.12	3.71	3.38	3.54	0.51	4.73	2.36	0.34	0.84	0.84
Hep-2 cells mock treated, biol_rep3	11900-125F1	6.14	2.28	2.28	4.55	0.23	5.46	2.28	0.46	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	6.12	3.94	3.61	5.14	0.87	5.03	1.86	1.09	0.98	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	7.74	1.93	2.36	2.79	0.21	5.59	2.36	0.86	1.07	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	5.38	2.15	1.94	3.01	0.43	3.88	1.72	0.43	0.86	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	7.60	4.23	3.49	3.74	0.75	3.99	1.49	0.25	1.00	0.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	11.15	2.92	4.80	3.95	0.51	3.26	2.74	0.17	0.86	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.37	2.24	4.81	3.20	0.64	1.60	2.56	0.32	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.19	2.80	4.48	2.24	0.56	0.56	2.24	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.19	0.87	1.30	0.87	1.30	0.43	0.00	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	26.44	10.58	13.22	5.29	2.64	5.29	23.79	0.00	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	4.94	2.12	1.41	1.06	2.47	1.06	0.35	0.71	1.06	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.81	2.91	2.18	2.18	1.45	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	24.30	18.36	12.59	3.15	13.11	1.22	4.72	3.32	0.70	2.45
Hepatocyte, donor1	11523-119I2	8.47	1.21	0.00	2.42	1.21	4.84	0.00	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	10.77	1.08	1.08	2.15	2.15	2.15	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	12.88	5.52	4.29	4.29	2.45	3.07	1.23	0.00	1.23	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	8.48	1.96	2.61	6.53	0.00	2.61	0.00	0.00	0.65	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	8.56	4.54	5.24	6.29	0.17	0.87	2.27	0.00	0.70	0.87
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.97	22.36	11.94	4.67	23.74	2.06	17.43	14.68	1.65	4.39
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	3.18	0.00	3.18	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	2.77	1.38	0.00	0.00	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	2.50	0.00	0.00	0.00	2.50	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	0.00	0.00	7.69	0.00	5.13	0.00	0.00	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	1.62	0.00	1.62	1.62	0.00	6.50	0.00	0.00	3.25	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	3.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	7.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	0.00	1.32	5.29	0.00	2.65	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	3.33	1.11	0.00	0.00	0.00	4.43	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	1.89	0.63	0.00	0.63	0.00	2.52	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	7.73	1.55	1.55	0.00	0.00	4.64	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	2.58	1.29	0.65	0.65	0.00	3.88	0.00	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	8.05	1.61	1.61	1.61	0.00	4.83	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	11.95	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	2.44	1.63	0.81	2.44	0.00	2.44	0.00	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	0.84	0.84	2.10	0.00	10.50	0.00	0.42	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	4.02	2.41	0.00	3.21	0.00	1.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.92	0.92	3.69	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	0.00	0.47	1.89	0.00	1.89	0.00	0.00	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.91	0.91	0.00	0.00	1.81	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	3.23	1.08	1.08	3.23	0.00	2.15	1.08	0.00	1.08	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	1.27	1.27	5.08	0.00	6.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	1.28	0.00	1.28	0.64	3.19	0.00	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	5.47	0.00	0.00	1.82	0.00	5.47	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	15.80	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	2.86	1.43	1.43	2.14	0.00	2.86	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	3.32	0.00	0.00	0.00	0.00	3.32	0.00	0.00	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.01	0.93	0.62	2.16	0.31	1.85	0.00	0.00	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	3.51	0.00	0.00	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	0.00	0.00	6.29	0.00	3.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	2.78	1.39	1.39	2.78	0.00	4.17	0.00	0.00	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	8.85	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	3.49	0.87	1.74	1.74	0.00	2.62	0.00	0.00	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	0.00	2.25	2.25	0.00	2.25	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	0.00	0.00	3.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	0.00	0.00	3.20	0.00	3.20	0.00	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	1.39	0.00	1.39	0.00	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	5.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	2.76	1.84	0.92	3.68	0.00	6.44	0.00	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	0.00	6.05	0.00	0.00	0.00	0.00	0.00	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	0.00	0.00	3.17	0.00	0.00	1.06	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	4.24	1.14	1.39	3.26	0.00	1.31	0.65	0.00	0.16	0.24
Keratinocyte - epidermal, donor2	11349-117G8	0.59	0.59	0.00	0.59	0.00	0.59	0.00	0.00	0.00	0.59
Keratinocyte - epidermal, donor3	11421-118F8	3.22	0.66	1.33	3.88	0.09	0.47	0.38	0.00	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	5.34	6.92	8.51	9.76	0.57	2.84	1.48	0.00	0.34	0.79
Keratocytes, donor1	11527-119I6	5.85	1.72	2.41	1.38	0.34	0.34	0.00	0.00	0.34	0.34
Keratocytes, donor2	11607-120I5	11.72	4.69	5.86	2.34	3.52	1.17	0.00	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	9.29	4.35	3.16	3.56	1.38	3.36	0.40	0.79	1.38	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	79.12	0.00	0.00	0.00	0.00	39.56	0.00	0.00	6.59	2.20
Lens Epithelial Cells, donor1	11529-119I8	18.34	5.39	7.55	2.16	4.31	0.00	12.94	2.16	4.31	2.16
Lens Epithelial Cells, donor2	11609-120I7	11.42	5.54	5.07	7.84	1.04	2.77	2.77	0.00	1.04	1.27
Lens Epithelial Cells, donor3	11690-122I7	22.20	12.31	16.25	4.24	5.95	3.13	14.73	0.71	2.02	4.34
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	4.86	4.86	5.45	3.08	1.66	0.71	0.95	0.00	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	2.79	2.79	1.95	1.40	0.56	1.12	0.28	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	5.98	5.82	4.25	3.62	0.94	1.73	0.79	0.16	1.57	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	3.23	2.69	3.23	1.61	0.54	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	2.52	3.47	2.84	2.21	0.63	0.95	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	1.62	2.48	2.70	2.16	0.43	0.54	0.11	0.11	0.32	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	7.39	5.75	2.87	1.64	0.41	3.28	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.53	0.51	1.01	0.51	0.25	0.51	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	2.96	3.24	2.11	0.84	0.28	0.42	0.00	0.00	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	7.91	1.58	2.77	0.79	2.77	2.37	0.79	0.00	0.79	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.27	3.88	2.91	3.30	0.39	0.97	0.78	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	0.56	1.48	0.74	0.56	0.19	0.93	0.19	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	3.83	3.83	6.27	1.74	0.70	1.39	0.35	0.00	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	1.43	2.39	1.91	2.15	0.24	0.72	0.24	0.24	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	3.16	1.65	2.47	0.55	0.27	0.41	0.41	0.14	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	8.01	4.93	3.08	1.54	1.54	0.62	0.00	0.31	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	0.31	1.56	0.62	0.94	0.00	1.25	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	1.83	2.56	2.20	0.91	0.18	0.73	0.37	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.59	0.33	5.27	1.97	1.65	1.32	0.66	0.00	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	1.17	1.17	0.59	1.46	0.00	1.17	0.29	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	2.24	0.75	0.75	1.00	0.25	0.25	0.00	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	5.33	3.39	1.94	2.42	1.45	0.97	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.04	1.62	2.96	2.15	1.08	1.35	0.54	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	3.03	2.72	3.03	1.51	0.91	1.06	0.30	0.00	0.76	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	8.29	3.63	3.63	0.52	1.56	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.33	2.72	2.30	3.14	1.05	1.47	0.42	0.00	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	2.41	2.86	2.11	0.90	0.15	0.30	0.00	0.00	0.45	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	7.57	2.75	1.38	2.06	2.06	1.38	2.06	0.69	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.76	3.39	2.26	1.69	1.32	0.38	0.56	0.19	0.94	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	1.48	2.54	1.91	0.85	0.64	1.06	0.21	0.00	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	6.78	4.85	3.88	1.94	0.97	0.97	0.00	0.00	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.31	3.31	1.65	1.65	0.33	0.99	0.66	0.00	0.66	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	2.85	1.61	1.86	0.99	0.25	0.62	0.12	0.00	0.12	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	7.77	8.14	5.55	4.81	1.85	1.11	1.11	0.00	1.85	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.20	2.47	2.96	0.74	0.49	0.99	0.49	0.25	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	1.79	1.10	2.89	0.82	0.00	0.96	0.00	0.27	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	7.40	3.54	4.50	4.82	0.32	2.25	0.96	0.32	0.96	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.39	2.74	4.26	2.13	1.52	1.22	0.91	0.30	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	5.60	3.64	3.36	1.68	0.84	1.26	0.70	0.00	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	4.62	4.27	2.49	1.07	0.36	1.07	1.07	0.00	0.71	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	3.39	1.94	0.97	0.97	0.48	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.71	1.56	1.56	0.62	0.31	0.31	0.16	0.00	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	4.30	3.94	2.15	1.79	0.72	0.72	2.15	0.00	0.72	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	2.61	2.61	0.98	1.31	0.33	0.65	0.00	0.33	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	0.47	1.41	1.41	0.00	0.00	0.24	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	5.82	3.59	4.58	1.98	1.86	0.87	1.11	0.00	0.87	0.87
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	1.02	2.05	1.02	0.77	0.00	0.51	0.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	2.39	0.90	2.09	0.30	0.90	1.19	0.00	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	0.00	2.27	0.00	0.00	4.53	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	5.37	3.07	2.30	0.00	0.00	3.84	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	1.48	0.74	1.48	0.74	2.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	3.81	2.12	1.27	1.27	0.42	3.39	0.00	0.00	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	3.52	0.70	2.11	2.11	1.41	0.70	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	0.00	1.87	1.87	0.00	0.93	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2.06	2.58	2.06	2.58	0.00	1.03	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	1.19	1.19	1.19	1.19	1.19	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	2.26	2.04	1.36	2.94	0.00	2.71	0.00	0.00	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	5.53	3.49	2.04	4.07	0.00	2.33	0.00	0.29	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	2.25	4.05	2.70	0.45	4.50	0.00	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	3.93	2.71	2.98	3.93	0.81	3.39	0.00	0.00	0.54	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.11	1.54	4.11	1.54	0.00	3.08	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	4.94	2.47	2.47	3.18	0.71	3.88	0.35	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.66	2.00	2.67	0.67	0.00	6.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	3.57	2.04	4.08	2.04	0.00	3.57	0.51	0.00	1.53	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.20	2.67	4.00	4.27	1.07	3.74	0.00	0.00	1.33	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	3.78	2.65	2.46	4.53	0.94	4.16	0.00	0.00	1.32	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	1.84	2.45	3.07	1.84	0.00	1.84	0.00	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	0.82	1.63	4.08	0.82	4.08	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4.58	4.58	4.37	4.79	0.62	4.79	0.21	0.00	1.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	5.61	2.24	2.80	2.80	1.12	2.52	0.00	0.28	1.68	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	2.06	0.00	3.09	2.06	0.00	2.06	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.64	1.74	5.23	2.90	2.32	4.94	0.29	0.00	2.03	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	5.38	2.39	2.09	3.29	0.90	3.59	0.30	0.00	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.30	0.55	2.21	2.21	0.55	4.43	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	5.66	1.77	2.83	3.53	0.71	3.53	0.00	0.00	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.06	1.11	3.32	0.74	0.37	3.32	0.00	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	1.15	2.30	2.30	3.45	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3.45	1.92	2.69	2.69	0.77	3.45	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2.26	2.83	2.26	2.26	0.57	2.83	0.00	0.00	1.13	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	2.46	1.64	0.82	0.00	3.28	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	3.16	3.16	2.26	1.36	0.90	4.07	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	3.59	2.87	2.15	0.72	1.44	3.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	10.46	2.99	2.99	1.49	0.75	5.23	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	4.46	1.86	2.23	1.86	1.49	3.34	0.00	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.31	3.88	1.72	3.88	0.43	1.72	0.00	0.00	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	4.28	0.86	2.57	2.57	1.71	4.28	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	3.33	3.66	3.66	0.67	0.33	3.00	0.00	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	3.02	0.60	1.21	0.00	4.83	0.00	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	2.13	2.13	1.42	2.13	1.42	2.13	0.00	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	3.78	2.75	2.41	3.44	1.37	3.78	0.00	0.00	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	2.68	3.22	3.76	0.54	1.61	2.68	0.00	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	2.69	3.37	0.67	2.02	2.02	3.37	0.00	0.00	1.35	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	4.07	4.44	3.33	1.85	0.37	1.11	0.00	0.00	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	2.33	0.00	0.00	0.00	4.65	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	3.17	0.00	3.17	0.00	0.00	3.17	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	3.60	1.60	2.40	2.00	1.60	4.40	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	2.91	2.91	3.63	0.73	0.00	3.63	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	2.30	0.00	1.53	0.77	0.00	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	3.45	1.97	2.96	0.99	0.49	1.48	0.00	0.49	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	4.70	2.82	2.82	0.94	0.00	1.88	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	1.51	3.02	2.51	2.51	0.50	2.51	0.00	0.00	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1.80	1.35	1.80	1.35	0.45	3.15	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	3.44	0.00	0.00	0.00	5.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	5.34	1.34	2.23	4.90	1.34	2.23	0.00	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	2.74	1.96	1.17	2.35	0.00	3.91	0.00	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	2.64	2.64	5.28	0.66	1.98	1.98	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.11	2.08	1.56	0.52	0.52	1.04	0.00	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	1.31	3.06	2.63	2.19	0.44	4.38	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	3.91	3.91	2.80	0.56	5.59	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	4.86	1.32	2.21	2.65	0.88	3.53	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	4.24	1.93	3.47	1.54	0.00	2.31	0.00	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	2.53	1.01	2.53	2.53	0.00	4.05	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	1.92	2.40	0.96	1.92	1.44	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	1.59	1.99	3.58	1.59	0.80	2.39	0.00	0.00	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	3.65	1.82	2.43	3.04	0.61	1.22	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	3.46	1.38	2.77	0.69	0.00	2.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	2.28	3.04	2.28	2.66	1.14	4.94	0.00	0.00	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	1.03	3.61	1.03	0.52	0.52	2.58	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.84	1.21	0.60	0.60	0.00	2.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.80	1.90	2.85	3.80	1.27	2.54	0.32	0.00	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3.20	1.07	2.13	2.13	0.00	1.60	0.00	0.00	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	1.15	0.00	1.72	0.57	0.00	2.30	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.14	1.54	2.06	0.51	0.00	1.03	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	3.54	2.83	2.12	1.41	0.00	3.54	0.00	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	0.00	3.40	1.70	0.00	0.57	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3.33	1.25	0.83	2.08	0.00	2.50	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.92	3.13	2.35	0.78	0.78	2.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	1.67	2.09	0.84	1.67	0.84	2.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	1.39	0.93	2.79	1.39	0.46	2.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	1.34	2.68	0.00	2.01	1.34	4.01	0.00	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	2.14	1.07	1.60	1.07	0.53	0.53	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	1.62	4.04	2.83	1.62	0.00	1.62	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	0.92	0.92	0.92	0.00	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	0.00	3.56	0.89	0.00	0.00	4.45	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	1.14	0.57	2.28	1.14	1.14	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	3.07	1.53	0.00	0.77	3.07	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.28	2.19	4.38	1.09	0.00	2.74	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	2.67	3.12	0.89	1.34	0.89	0.45	0.45	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	2.08	1.04	2.08	2.08	1.30	2.60	0.00	0.00	0.00	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	1.99	3.32	1.33	0.66	1.33	1.33	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	0.00	4.16	2.08	0.00	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	12.31	1.14	1.60	7.29	0.46	1.82	0.68	0.00	1.60	0.23
Macrophage - monocyte derived, donor2	11313-117C8	4.59	0.18	0.18	3.85	0.92	2.57	0.55	0.18	1.10	0.00
Macrophage - monocyte derived, donor3	11389-118C3	7.21	0.79	0.52	4.72	0.00	2.10	0.39	0.00	1.05	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	2.12	2.12	1.06	1.59	0.53	0.53	0.53	0.53	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	8.87	2.22	2.54	3.96	0.32	2.38	1.43	0.00	0.79	0.32
Mallassez-derived cells, donor3	11930-125I4	8.90	1.53	1.53	3.20	0.14	1.95	1.67	0.00	0.56	0.00
Mammary Epithelial Cell, donor1	11273-116H4	6.18	4.58	2.49	7.57	0.20	2.89	0.30	0.10	0.60	0.70
Mammary Epithelial Cell, donor2	11350-117G9	7.82	1.74	1.74	2.32	0.29	2.03	1.16	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	2.00	1.75	0.50	2.49	0.25	0.75	0.25	0.00	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	4.07	1.36	4.07	10.17	0.68	4.07	0.68	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	15.68	1.41	2.92	3.68	1.41	3.14	0.87	0.00	2.49	0.76
Mast cell, donor2	11565-120D8	14.86	6.24	11.89	7.13	0.00	4.75	0.30	0.30	0.89	0.59
Mast cell, donor3	11566-120D9	18.91	7.88	15.76	6.08	1.58	4.28	0.45	0.45	0.90	0.68
Mast cell, donor4	11567-120E1	13.12	5.85	16.31	6.91	0.00	3.72	0.35	0.35	1.60	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	18.74	1.66	2.66	3.77	1.89	11.09	1.11	0.22	1.66	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	9.34	2.33	5.84	3.50	1.75	7.59	2.92	0.00	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	6.54	0.57	2.41	3.33	0.34	4.36	0.57	0.00	0.34	0.23
Mast cell, expanded, donor8	11941-126A6	20.08	3.18	4.18	7.20	1.00	6.03	1.17	0.00	1.67	1.00
Melanocyte - dark, donor1	11502-119F8	7.96	10.15	10.85	5.77	1.79	1.59	4.08	0.30	1.19	1.49
Melanocyte - dark, donor2	11582-120F7	33.57	36.34	18.34	3.81	29.76	0.00	26.65	3.81	1.04	4.85
Melanocyte - dark, donor3	11663-122F7	9.27	1.16	0.80	5.00	0.51	0.58	0.43	0.07	0.87	0.65
Melanocyte - light, donor1	11274-116H5	5.17	0.71	0.94	1.41	0.00	0.24	0.24	0.00	0.24	0.00
Melanocyte - light, donor2	11351-117H1	2.73	0.00	1.36	0.68	0.00	0.68	0.68	0.00	0.68	0.00
Melanocyte - light, donor3	11423-118G1	2.60	2.60	1.73	0.87	2.60	0.00	0.00	3.47	0.00	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	7.18	0.94	1.46	2.60	1.25	0.21	1.25	1.04	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	9.95	2.42	1.08	4.57	1.34	0.54	2.69	0.27	0.27	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	23.30	5.36	3.75	2.68	0.80	1.34	1.87	0.00	2.14	1.34
Meningeal Cells, donor1	11493-119E8	16.13	7.57	5.95	2.23	4.47	1.86	1.49	0.50	0.62	1.12
Meningeal Cells, donor2	11573-120E7	16.29	1.76	3.08	0.44	1.76	2.64	0.00	0.44	1.32	1.32
Meningeal Cells, donor3	11654-122E7	21.19	11.74	8.48	7.66	9.78	4.32	4.73	1.06	1.47	1.96
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	28.23	23.95	13.97	5.42	20.82	1.71	2.00	8.27	3.14	4.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	15.09	10.37	9.16	3.22	11.87	2.11	7.04	1.31	0.91	1.41
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	9.20	3.94	0.00	3.94	2.63	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	9.16	5.23	6.54	1.31	5.23	0.00	0.00	1.31	0.00	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	35.16	14.35	9.33	3.59	15.07	1.44	1.44	5.02	1.44	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.72	13.55	9.95	2.54	20.97	1.69	5.93	2.54	0.85	2.12
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.75	18.60	8.54	2.01	24.63	1.01	9.55	6.03	1.51	3.52
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	12.31	4.61	2.42	1.32	1.54	0.88	0.44	0.44	1.32	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	2.19	0.73	2.19	2.19	0.00	0.73	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	13.50	3.27	1.84	1.02	2.46	0.82	0.00	1.02	0.41	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	18.70	15.79	9.97	2.77	6.93	2.22	0.14	1.52	0.83	1.52
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	2.97	1.86	5.20	1.49	1.86	0.37	1.86	1.12	0.00	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	23.55	45.39	14.21	6.05	15.26	1.45	21.05	3.03	2.11	1.71
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	9.50	2.08	2.37	1.48	2.37	0.00	1.48	0.59	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	2.34	0.00	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	10.25	6.40	5.12	0.00	3.20	0.00	0.00	1.28	0.64	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	33.32	16.30	10.28	4.96	33.67	0.71	3.90	4.25	0.35	2.48
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.26	30.33	8.76	6.25	11.26	0.94	15.32	2.81	2.19	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	24.67	12.34	9.43	2.18	12.34	2.18	2.90	9.43	0.00	5.08
Mesothelial Cells, donor1	11247-116E5	28.11	18.83	11.93	2.12	62.85	1.06	56.75	44.81	0.80	1.86
Mesothelial Cells, donor2	12156-128G5	7.51	9.01	5.00	1.50	25.52	1.50	37.03	15.01	0.00	3.00
Mesothelial Cells, donor3	11402-118D7	28.62	11.56	9.39	2.31	22.26	1.95	20.96	20.16	1.59	2.53
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	4.05	1.35	1.35	0.00	16.20	0.00	0.00	4.05	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.81	1.97	2.22	3.69	0.74	5.91	0.49	0.00	1.48	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	6.77	0.59	0.88	1.77	0.29	5.89	0.59	0.00	1.47	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00	0.00	0.00	0.00	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	8.37	1.86	4.96	3.72	0.31	2.79	1.24	0.00	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	3.73	1.45	0.83	3.53	0.83	4.15	0.41	0.00	0.62	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	2.32	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	8.51	1.50	3.00	3.00	0.75	2.75	0.25	0.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	8.84	0.93	0.00	4.19	0.47	9.31	1.40	0.00	1.86	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	38.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	7.52	0.41	3.66	3.25	1.02	3.25	0.20	0.00	1.22	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.96	0.00	1.58	1.98	0.40	4.75	0.00	0.00	1.19	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.88	1.77	4.42	0.00	2.65	0.00	0.00	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	4.56	0.38	0.38	3.04	0.00	4.94	0.38	0.00	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	0.00	0.00	1.32	0.00	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	7.22	0.85	0.64	2.33	0.00	2.33	1.27	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	4.60	0.92	0.92	1.84	0.00	4.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	0.89	1.19	0.89	0.60	2.09	0.00	0.00	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	8.38	1.68	0.00	0.00	0.00	6.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.01	1.00	0.75	0.50	0.50	2.01	1.00	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	5.94	0.24	0.48	3.80	0.71	5.70	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	2.76	0.55	1.66	1.66	0.00	0.55	0.00	0.00	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	6.68	0.00	1.15	2.07	1.84	1.61	1.84	0.00	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.47	0.42	0.42	3.16	0.63	5.26	0.42	0.00	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	5.30	0.61	1.63	2.85	0.41	2.65	0.20	0.00	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	5.15	1.29	1.50	2.79	0.64	1.07	0.86	0.00	0.86	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	6.00	0.00	0.67	1.33	0.67	5.78	0.44	0.00	0.89	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.13	0.66	0.88	2.63	0.00	2.41	0.00	0.00	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	3.04	0.00	0.51	2.03	0.00	6.59	0.00	0.00	3.04	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	3.31	0.00	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	0.54	2.45	3.26	0.82	2.72	0.00	0.00	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.06	0.59	0.88	2.35	1.18	5.59	0.00	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	1.09	0.00	0.00	1.09	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	2.40	0.00	1.44	1.92	0.48	3.36	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	0.00	0.80	3.20	1.20	2.40	0.00	0.00	1.60	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	10.97	1.37	1.37	1.37	0.00	8.23	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	5.01	0.50	1.00	3.00	2.00	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	0.00	0.00	0.00	0.00	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	0.88	1.75	2.63	1.31	2.19	0.00	0.00	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	0.00	0.00	0.00	0.00	4.41	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	16.65	0.64	0.00	0.64	0.64	3.84	0.00	0.00	1.92	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	8.18	1.74	0.50	2.48	1.74	1.24	0.50	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	0.00	0.00	0.70	1.39	2.78	0.70	0.00	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	0.00	0.00	0.00	0.00	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.13	0.34	0.68	4.44	2.05	0.68	0.68	0.00	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	0.00	0.44	0.44	1.31	2.63	0.44	0.00	0.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.85	1.42	0.36	1.78	1.78	3.20	0.00	0.00	0.71	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.89	0.00	0.56	3.65	1.96	1.40	0.84	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	3.33	0.42	0.42	2.08	0.42	2.91	0.00	0.00	2.08	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	0.00	0.00	0.58	0.58	1.75	0.00	0.00	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.54	1.21	1.51	3.02	2.11	1.81	0.60	0.30	1.21	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	4.17	1.25	2.09	3.76	2.09	2.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	0.00	0.92	2.77	0.00	0.92	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.81	0.00	0.00	1.71	2.85	2.85	0.57	0.00	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	13.96	0.28	1.80	2.49	2.35	2.35	0.28	0.00	0.69	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	7.52	0.26	2.85	3.11	3.63	1.30	0.00	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	11.15	0.86	2.57	0.43	1.72	2.57	0.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	0.64	0.64	1.27	1.27	0.64	0.00	0.00	4.45	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	0.27	0.80	2.14	2.94	2.67	0.53	0.00	2.40	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	11.08	1.50	1.50	2.69	1.50	3.29	0.30	0.00	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	9.32	0.28	0.57	1.70	0.71	1.41	0.14	0.00	0.28	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	0.96	1.27	1.27	2.55	0.96	0.32	0.32	1.27	0.32
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.28	0.22	0.88	2.21	3.10	3.10	0.44	0.00	1.11	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	19.34	0.76	1.90	1.14	1.52	3.03	0.38	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	11.65	1.42	0.85	5.40	3.13	3.13	0.57	0.00	0.85	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.65	1.47	1.47	3.20	2.46	2.46	0.98	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	24.11	0.00	1.96	1.30	0.00	2.61	0.00	0.00	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.17	2.35	1.47	1.47	1.47	1.47	0.29	0.00	1.47	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.80	0.86	0.00	2.02	0.86	5.77	0.58	0.00	1.73	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	14.84	1.65	1.65	2.06	0.82	3.30	0.00	0.00	2.89	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	10.12	0.89	1.49	2.38	0.60	2.08	0.30	0.00	1.49	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	0.00	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	1.78	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	12.49	1.97	4.60	4.60	0.99	1.64	1.31	0.00	1.97	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	1.05	1.05	2.10	1.05	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.08	1.38	2.57	5.54	0.99	1.38	0.20	0.00	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	10.24	0.93	0.00	1.86	1.86	1.86	0.93	0.00	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	11.64	0.00	2.63	3.00	0.00	0.75	0.38	0.00	1.50	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	4.79	0.27	0.53	2.40	0.27	2.66	0.00	0.00	1.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	5.88	0.68	0.68	1.81	0.23	1.02	0.45	0.00	1.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	7.37	0.74	1.47	2.95	0.00	1.47	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	12.09	1.83	1.47	2.20	0.73	0.73	0.73	0.00	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	4.67	1.56	0.00	1.56	4.67	3.11	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.95	0.53	1.60	1.60	1.07	1.60	0.00	0.00	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	7.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	0.00	1.01	5.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	0.42	0.84	3.37	0.00	1.26	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	0.00	1.36	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.64	0.64	1.91	1.27	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	0.00	0.81	4.05	1.62	0.00	0.00	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	6.04	0.00	4.53	1.51	0.00	1.51	1.51	0.00	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	3.26	0.00	9.79	3.26	6.52	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	16.59	7.54	6.68	4.74	10.77	1.94	7.11	1.08	0.86	1.08
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	21.95	9.93	7.32	1.57	1.57	2.09	1.05	0.00	1.57	3.66
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	52.06	20.02	34.04	4.00	6.01	2.00	2.00	2.00	2.67	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	42.57	8.35	10.85	2.92	2.50	1.67	0.83	0.83	3.34	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	112.94	15.59	26.05	7.42	8.94	3.42	1.14	0.57	5.13	8.37
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	82.98	12.77	19.15	3.19	15.96	7.98	1.60	0.00	4.79	4.79
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.24	19.72	21.08	1.36	8.16	2.04	0.68	2.04	3.40	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	14.70	9.19	7.35	5.51	14.70	9.19	3.68	3.68	1.84	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	18.00	23.86	2.93	3.77	2.51	0.84	0.00	0.42	4.19
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	49.97	21.85	28.59	3.95	11.85	1.16	1.39	1.86	2.79	4.65
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	41.34	15.40	24.05	4.59	1.08	2.43	0.00	0.00	2.43	3.24
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	57.60	10.30	11.56	3.36	2.73	2.94	0.21	0.42	1.47	3.99
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	33.40	44.54	22.27	44.54	22.27	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.82	16.38	15.88	4.47	2.98	0.99	0.99	0.50	1.99	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	51.16	14.35	19.49	3.25	2.44	2.17	0.00	0.54	3.52	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.07	21.08	25.84	5.67	8.16	1.36	0.68	0.91	1.59	4.76
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	36.58	12.08	15.35	2.94	1.47	1.80	0.49	0.00	2.61	3.27
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	34.63	10.21	12.21	3.46	4.74	3.65	0.91	0.73	2.00	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	38.19	25.99	22.81	2.12	4.77	2.12	0.53	1.06	0.53	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	31.22	15.61	24.01	3.60	3.00	2.40	0.00	0.00	1.20	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	100.42	23.96	28.22	7.22	4.59	3.61	0.66	0.33	4.59	5.25
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	47.97	16.10	23.74	4.55	5.37	0.98	0.65	0.33	2.44	3.90
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	59.79	9.88	11.46	3.88	5.64	3.88	0.71	0.53	5.12	3.17
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	15.47	17.58	2.81	5.63	1.41	2.81	1.41	0.70	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	37.70	16.55	20.69	5.06	3.68	0.46	0.46	0.00	0.46	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	19.28	18.96	23.46	1.61	1.93	0.64	0.96	0.32	2.25	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	120.71	22.42	23.45	5.86	7.24	3.45	2.76	0.69	7.24	5.17
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	42.98	7.59	7.59	0.00	0.00	25.28	0.00	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	46.34	9.13	9.36	2.45	3.34	3.56	0.45	0.00	1.34	5.12
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	41.07	9.74	25.40	5.93	6.77	0.85	0.85	0.42	0.42	2.54
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	47.71	18.75	26.58	3.56	2.61	0.71	0.00	0.47	2.61	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	26.61	12.88	16.74	3.86	3.86	0.86	0.00	0.86	1.72	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	63.19	27.08	18.06	0.00	18.06	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	35.32	10.00	14.66	3.33	1.33	1.67	0.33	0.00	1.67	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	49.59	6.31	9.47	1.80	1.35	3.16	0.45	0.00	3.16	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.05	9.92	15.08	2.78	5.56	0.79	0.79	0.79	1.59	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	28.79	14.86	14.86	2.79	0.00	0.93	0.00	0.00	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	24.22	15.13	21.57	3.78	2.65	0.38	1.14	0.00	1.89	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	29.66	12.71	12.38	3.26	4.56	2.93	1.63	0.00	0.98	2.61
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	28.76	6.97	11.77	3.92	0.44	2.18	0.00	0.00	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	48.39	7.24	8.14	1.81	2.26	3.17	1.36	0.00	3.62	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	26.46	11.46	22.05	6.17	11.46	0.00	3.53	0.88	0.00	3.53
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	15.29	19.28	1.33	0.00	0.66	0.00	1.33	1.33	2.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.29	15.87	24.80	1.49	0.99	0.00	0.00	0.00	1.49	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	32.54	10.72	17.23	1.53	3.83	2.68	0.00	0.00	1.53	3.45
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.34	3.93	5.44	2.42	0.30	2.12	0.60	0.30	1.81	2.12
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	36.03	6.63	8.18	2.87	2.65	3.54	1.55	0.22	1.55	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.75	17.62	23.72	4.07	9.49	0.00	2.03	0.00	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	15.33	5.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	20.73	7.93	19.51	1.22	2.44	1.83	1.22	0.00	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	29.27	11.33	11.02	2.83	1.57	1.57	0.63	0.31	2.83	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	36.62	13.01	17.55	4.84	1.21	2.42	0.30	0.00	1.82	2.42
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	29.27	11.08	13.45	3.96	3.16	2.37	2.37	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	97.49	15.87	10.20	5.67	5.67	5.67	5.67	0.00	2.27	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	10.12	0.00	5.06	10.12	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	14.53	7.83	8.07	4.47	13.91	1.99	3.48	4.97	0.99	1.61
Myoblast, donor2	11322-117D8	36.63	17.07	10.93	3.64	20.14	2.30	5.18	6.14	3.07	5.18
Myoblast, donor3	11398-118D3	24.22	8.58	10.26	7.40	18.16	1.85	6.89	5.38	2.69	2.69
NK T cell leukemia cell line:KHYG-1	10777-110G3	11.97	1.75	0.88	2.48	1.17	0.73	0.88	0.15	0.58	0.58
Natural Killer Cells, donor1	11230-116C6	23.37	1.85	1.85	3.69	6.15	1.23	1.23	0.31	1.54	1.85
Natural Killer Cells, donor2	11311-117C6	18.39	1.21	2.41	1.51	0.60	2.41	0.30	0.30	0.60	1.51
Natural Killer Cells, donor3	11387-118C1	19.14	0.74	3.13	2.58	1.66	2.39	0.18	0.55	0.74	2.02
Neural stem cells, donor1	11275-116H6	14.15	10.16	5.81	7.26	2.90	10.16	1.45	0.00	5.08	1.09
Neural stem cells, donor2	11352-117H2	28.88	13.48	11.55	1.93	1.93	1.93	1.93	0.00	1.93	1.93
Neurons, donor1	11494-119E9	11.38	4.55	3.41	4.55	2.28	4.55	0.00	1.14	0.00	1.14
Neurons, donor2	11574-120E8	10.79	9.47	4.40	5.06	0.00	8.15	1.32	0.22	1.32	0.66
Neurons, donor3	11655-122E8	13.98	6.58	5.76	4.11	0.82	1.64	1.64	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	105.79	13.92	36.19	5.57	5.57	5.57	0.00	0.00	5.57	7.42
Neutrophils, donor2	11314-117C9	49.28	17.39	11.60	0.00	2.90	5.80	0.00	0.00	8.70	8.70
Neutrophils, donor3	11390-118C4	197.30	32.99	54.98	17.71	11.61	4.89	0.00	0.61	19.55	17.10
Nucleus Pulposus Cell, donor1	11252-116F1	97.01	323.44	113.87	12.11	181.31	3.09	18.88	125.62	4.87	17.93
Nucleus Pulposus Cell, donor2	11409-118E5	37.12	89.87	36.47	3.58	25.07	2.93	2.28	21.82	3.26	4.23
Nucleus Pulposus Cell, donor3	11462-119B4	25.67	37.70	11.83	2.61	15.44	1.20	2.01	13.44	1.00	0.80
Olfactory epithelial cells, donor1	11933-125I7	54.23	52.03	34.96	3.17	25.47	1.79	21.06	9.64	3.03	6.61
Olfactory epithelial cells, donor2	11934-125I8	41.25	34.02	26.49	4.49	19.97	1.01	17.37	3.76	3.91	6.37
Olfactory epithelial cells, donor3	11935-125I9	40.98	29.51	23.50	4.20	12.83	1.59	13.51	2.95	3.75	4.54
Olfactory epithelial cells, donor4	11936-126A1	42.95	38.08	31.56	3.60	13.54	1.75	9.74	2.63	2.53	2.82
Oligodendrocyte - precursors, donor1	11496-119F2	15.65	9.63	6.02	6.62	7.22	1.81	3.61	1.81	1.20	3.01
Osteoblast - differentiated, donor1	11276-116H7	7.87	5.10	5.32	1.28	0.85	1.28	0.64	0.00	1.49	0.85
Osteoblast - differentiated, donor2	11353-117H3	2.29	2.29	1.14	0.00	1.14	4.57	0.00	0.00	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	10.55	4.34	0.62	4.97	3.72	3.72	0.62	1.24	0.62	0.00
Osteoblast, donor1	11277-116H8	3.91	2.74	2.15	1.37	0.78	0.78	0.00	0.00	0.59	1.17
Osteoblast, donor2	11354-117H4	20.37	4.21	10.53	4.92	5.62	3.51	2.11	0.70	0.70	1.40
Osteoblast, donor3	11426-118G4	8.18	4.98	4.09	2.49	1.78	1.24	0.00	0.36	0.53	1.24
Pancreatic stromal cells, donor1	11249-116E7	24.01	10.11	10.87	7.58	11.12	2.36	1.68	1.26	1.35	3.79
Pericytes, donor1	11491-119E6	1.89	1.45	2.45	0.45	0.22	0.56	0.11	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	2.72	1.36	0.45	0.45	0.00	1.13	0.68	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	8.34	4.27	5.70	1.22	2.64	0.41	0.61	0.61	0.20	0.81
Perineurial Cells, donor1	11499-119F5	13.56	8.93	7.01	7.46	4.52	3.05	2.15	1.13	1.13	2.26
Perineurial Cells, donor2	11579-120F4	35.15	66.80	32.48	6.16	36.71	0.92	53.00	13.07	4.05	9.29
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	39.20	4.78	4.78	5.10	2.23	4.14	1.91	0.96	0.96	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.18	0.49	1.96	5.63	1.22	1.47	0.24	0.24	0.98	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	18.89	0.78	3.11	3.24	0.91	1.68	0.26	0.13	1.16	1.29
Placental Epithelial Cells, donor1	11278-116H9	0.96	0.48	0.72	0.96	0.00	1.20	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	2.22	0.00	2.22	2.22	0.00	4.44	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.12	2.16	1.77	0.59	1.37	0.59	0.20	0.20	0.00	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	10.76	4.43	5.06	0.95	0.63	1.58	0.32	0.00	0.32	0.32
Preadipocyte - breast, donor1	11467-119B9	8.25	6.19	7.69	3.38	3.56	2.81	0.56	0.00	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	19.97	10.18	5.09	4.18	9.27	1.70	1.83	0.39	1.17	3.13
Preadipocyte - breast, donor2	11328-117E5	9.68	3.83	4.95	1.13	0.68	0.90	0.23	0.00	1.80	0.45
Preadipocyte - omental, donor1	11468-119C1	13.43	10.34	12.47	3.41	5.86	3.20	1.39	1.28	1.60	1.07
Preadipocyte - omental, donor2	11329-117E6	13.97	13.09	14.40	3.93	11.35	3.06	2.62	0.87	3.49	0.87
Preadipocyte - omental, donor3	11403-118D8	15.47	4.15	5.01	2.29	5.87	2.29	0.29	0.57	0.43	0.86
Preadipocyte - perirenal, donor1	11469-119C2	7.87	7.87	2.95	0.98	3.94	0.98	2.95	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.14	0.92	2.46	0.61	3.99	0.31	0.92	0.00	0.61	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	17.88	5.67	4.60	3.19	4.96	2.12	1.06	0.18	1.06	1.59
Preadipocyte - subcutaneous, donor3	11428-118G6	13.96	2.89	1.02	3.75	4.26	2.21	0.34	0.68	0.85	0.68
Preadipocyte - visceral, donor1	11280-116I2	28.22	9.69	9.31	7.92	15.37	3.91	2.05	1.02	1.68	2.05
Preadipocyte - visceral, donor2	11357-117H7	29.45	19.33	11.50	0.00	15.19	1.84	5.06	1.84	1.38	1.38
Preadipocyte - visceral, donor3	11429-118G7	18.60	5.12	3.76	2.72	7.31	1.46	2.51	0.94	1.04	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	4.53	6.64	6.94	3.17	0.60	0.91	1.36	0.30	0.75	1.36
Prostate Epithelial Cells, donor2	11331-117E8	8.67	2.30	1.62	2.84	0.68	0.54	1.08	0.00	1.62	0.68
Prostate Epithelial Cells, donor3	11404-118D9	4.96	0.73	0.80	4.16	0.18	1.78	0.12	0.06	0.55	0.12
Prostate Stromal Cells, donor1	11254-116F3	10.36	5.58	4.21	6.04	8.09	0.91	0.80	0.80	0.80	2.16
Prostate Stromal Cells, donor2	11332-117E9	18.65	4.84	5.38	2.15	5.02	1.61	1.43	1.08	2.33	1.26
Prostate Stromal Cells, donor3	11405-118E1	12.93	5.42	3.86	3.75	4.17	1.25	0.73	0.52	1.67	0.73
Renal Cortical Epithelial Cells, donor1	11516-119H4	0.00	1.82	1.46	1.82	0.00	1.09	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	4.30	4.64	3.95	5.06	0.28	2.50	0.62	0.07	0.90	0.28
Renal Epithelial Cells, donor1	11517-119H5	3.04	2.03	1.01	1.01	0.51	0.51	0.00	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	0.71	0.71	0.71	0.00	0.00	0.00	0.71	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	6.14	7.94	6.46	6.25	1.48	2.65	1.16	0.42	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	6.81	2.04	3.40	0.00	0.00	0.00	0.00	0.68	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	16.98	6.06	5.79	0.94	2.56	0.40	2.29	0.27	0.81	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	24.64	10.21	7.33	4.00	3.55	2.66	2.22	0.67	0.89	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	6.65	2.00	1.33	0.67	0.67	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	3.96	3.08	1.76	0.44	0.00	0.44	0.66	0.00	0.00	1.32
Renal Mesangial Cells, donor2	11598-120H5	2.51	2.51	1.25	0.63	1.25	0.63	0.63	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	1.94	1.94	0.83	0.28	0.55	0.00	0.00	0.00	0.28	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	2.42	0.27	1.07	1.88	0.00	1.61	0.27	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	1.27	0.42	0.42	2.11	0.00	1.27	0.00	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.70	1.74	1.16	0.77	0.19	0.58	0.19	0.00	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	12.70	5.96	2.33	5.44	1.04	1.04	1.81	0.52	0.78	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.23	6.54	5.68	1.71	1.99	1.99	5.68	0.28	0.00	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	1.03	0.00	2.06	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	7.78	13.80	5.27	7.53	1.00	3.51	2.01	0.50	2.51	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	13.36	6.15	9.49	5.48	0.53	5.88	0.13	0.00	2.27	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	40.20	3.57	1.79	4.47	0.00	2.68	0.89	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	57.79	3.85	8.26	3.30	2.75	9.91	1.10	0.55	4.40	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	69.03	4.64	2.90	5.80	2.32	10.44	0.00	0.00	1.74	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	40.31	5.98	5.85	3.38	2.21	5.59	2.08	0.26	0.52	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	30.59	3.28	2.38	4.67	1.59	3.18	1.09	0.10	3.18	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	27.55	3.79	1.90	4.46	3.23	4.24	1.90	0.11	1.90	1.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.21	4.84	2.36	4.59	2.73	3.23	2.98	0.50	1.49	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	32.98	3.15	2.56	3.61	1.05	2.68	1.05	0.12	1.86	1.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	37.44	4.39	2.54	6.01	2.08	5.55	1.85	0.00	4.16	1.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	42.58	3.15	2.60	2.60	1.10	5.34	0.41	0.27	1.37	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	33.89	6.05	3.18	4.24	2.42	6.66	1.21	0.30	1.36	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	22.76	3.58	2.51	6.45	2.33	3.40	2.51	0.18	1.61	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	35.86	3.44	2.58	2.30	1.43	5.02	1.72	0.00	1.15	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	28.87	2.04	2.47	3.76	1.93	3.54	1.07	0.21	1.61	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	29.21	1.99	2.21	3.32	2.88	2.43	0.44	0.00	2.21	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	52.76	3.44	2.49	3.82	2.10	8.41	0.76	0.38	1.53	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	32.51	3.17	3.54	3.17	1.77	5.78	0.84	0.00	2.24	2.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.33	6.20	4.32	6.39	3.57	6.95	2.44	0.19	2.07	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	51.22	3.98	2.79	2.12	1.59	4.91	0.93	0.27	2.65	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	37.38	2.43	2.53	2.73	1.36	4.87	0.97	0.19	2.24	1.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	34.18	3.06	2.48	4.58	1.72	3.44	1.34	0.00	2.48	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	38.02	4.70	2.78	3.20	1.50	5.23	1.60	0.21	1.71	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	29.43	3.64	2.52	3.08	1.68	4.48	0.84	0.28	1.96	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	39.99	2.05	1.71	3.08	2.39	5.30	0.68	0.17	3.25	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	42.48	5.11	2.37	2.19	1.46	5.65	1.09	0.00	1.82	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	31.03	2.08	1.72	3.07	1.72	5.27	0.37	0.00	2.33	2.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	31.30	1.75	1.34	3.76	1.75	4.84	0.94	0.27	1.34	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	39.39	4.95	4.25	3.54	1.65	7.31	3.07	0.24	1.89	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	32.34	2.78	2.78	4.17	1.19	3.57	0.99	0.00	0.99	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	35.08	3.51	3.98	4.91	1.64	5.38	1.17	0.00	3.98	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	33.59	4.15	3.53	2.49	1.87	5.39	0.41	0.00	1.24	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.08	5.09	1.99	2.65	2.21	4.87	1.55	0.22	2.43	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	43.03	1.67	1.46	3.76	0.84	5.64	0.21	0.00	1.88	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	37.82	3.36	2.29	2.15	1.62	6.06	0.81	0.13	0.81	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	42.40	4.09	4.60	4.94	0.85	4.60	0.17	0.34	2.72	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	36.25	1.93	1.54	5.21	1.74	7.33	0.58	0.39	2.12	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	48.49	4.64	4.81	2.75	2.75	8.77	2.24	0.34	2.06	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	37.72	2.88	2.61	2.74	1.78	5.62	0.27	0.00	2.61	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	43.01	3.45	4.10	3.78	3.94	7.39	0.99	0.16	2.13	2.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	55.73	6.14	3.92	1.87	2.56	7.84	1.19	0.17	2.39	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	39.95	4.14	4.73	4.29	2.81	5.18	0.44	0.30	2.52	4.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	65.84	4.00	4.00	3.20	2.13	6.40	1.87	0.00	4.80	4.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	30.70	1.66	1.80	2.63	0.55	4.01	0.28	0.00	1.66	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.95	1.43	1.19	2.38	1.43	2.14	0.00	0.00	2.14	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	70.94	4.43	3.83	5.24	2.42	10.68	1.21	0.40	4.84	3.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.84	2.35	1.70	3.86	0.94	3.48	0.57	0.28	1.51	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	30.05	3.84	2.45	6.29	0.00	4.89	0.70	0.00	1.40	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	30.83	3.32	1.21	2.42	1.81	7.25	0.00	0.00	2.12	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	27.05	3.67	2.33	2.08	0.98	3.67	0.37	0.98	1.10	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	35.81	6.84	4.51	5.97	2.91	4.66	0.58	0.29	3.35	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	2.43	3.04	3.04	0.00	4.26	0.00	0.61	2.43	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	27.13	3.62	3.62	2.71	1.81	4.82	0.60	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	26.24	4.30	3.17	3.62	1.58	5.20	0.23	0.23	2.26	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.06	2.40	2.40	5.69	1.20	3.59	0.00	0.30	4.19	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.88	3.90	4.37	2.24	0.59	5.31	0.35	0.12	0.47	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.41	4.27	2.99	3.84	1.07	4.27	0.43	0.64	0.64	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	27.64	8.41	4.21	7.21	0.60	4.21	0.00	0.00	1.20	1.80
Schwann Cells, donor1	11498-119F4	8.09	4.14	1.69	0.56	1.69	0.56	0.38	0.19	0.75	0.38
Schwann Cells, donor2	11578-120F3	10.21	20.41	13.61	0.00	3.40	13.61	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	17.53	8.76	9.20	3.72	4.16	1.10	0.88	0.88	0.44	1.31
Sebocyte, donor1	11220-116B5	2.74	1.10	0.55	2.74	0.00	1.10	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	2.30	0.46	0.00	0.92	0.00	0.46	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	4.53	1.44	0.82	1.44	0.21	1.44	0.21	0.62	0.62	0.21
Sertoli Cells, donor1	11255-116F4	16.57	4.97	8.28	11.60	8.28	1.66	3.31	3.31	3.31	3.31
Sertoli Cells, donor2	11333-117F1	14.12	33.89	19.77	0.00	5.65	5.65	5.65	5.65	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	5.01	3.26	1.94	2.73	0.09	2.82	0.00	0.00	0.53	0.53
Skeletal Muscle Cells, donor2	11358-117H8	4.34	0.72	3.61	2.17	0.00	0.72	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	8.36	0.84	0.84	0.84	2.51	1.67	0.00	0.00	0.84	1.67
Skeletal Muscle Cells, donor4	11451-119A2	22.78	16.02	9.11	3.46	9.90	1.41	2.98	3.77	1.41	1.73
Skeletal Muscle Cells, donor5	11455-119A6	21.11	9.07	7.88	1.93	6.39	1.93	1.19	1.78	0.74	0.45
Skeletal Muscle Cells, donor6	11459-119B1	25.86	17.39	6.62	2.92	7.39	1.08	2.31	5.08	0.62	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.18	23.31	13.48	11.72	6.55	3.02	0.76	1.89	1.76	2.77
Skeletal Muscle Satellite Cells, donor2	11321-117D7	21.69	17.12	7.56	4.57	5.14	1.71	0.43	2.28	0.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.69	12.90	5.85	4.37	9.52	2.48	1.79	2.58	2.38	3.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	7.25	3.88	2.70	2.95	0.84	2.70	0.08	0.00	0.67	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.90	0.72	2.17	2.17	0.72	0.72	0.00	0.72	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	3.30	1.38	2.06	0.41	0.83	0.28	0.14	0.00	1.10	0.00
Skin - palm, donor1	10286-104F7	34.92	5.37	18.80	2.69	0.00	2.69	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	6.78	0.86	1.44	1.73	0.00	1.15	1.01	0.00	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.17	2.45	0.82	2.45	0.82	2.45	3.27	0.00	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	7.14	1.82	1.82	2.47	0.13	0.52	0.26	0.13	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	4.87	1.81	1.95	6.67	0.28	1.53	0.70	0.28	0.70	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	10.13	0.98	2.11	2.39	0.28	1.83	0.14	0.00	0.70	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	13.96	2.75	2.75	7.61	1.48	2.96	3.17	0.00	0.42	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	8.32	0.52	1.20	3.37	0.07	2.40	0.00	0.00	0.90	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.76	7.71	10.49	2.16	6.17	1.54	1.23	7.71	1.23	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.79	10.45	7.11	3.11	25.79	2.45	3.33	23.79	0.89	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	12.34	14.70	3.53	1.76	21.75	1.18	4.11	5.88	2.94	5.29
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.96	7.29	4.42	1.77	5.08	0.44	1.10	0.66	0.88	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	2.76	1.58	1.18	3.94	1.18	1.97	1.18	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	16.22	17.77	8.50	0.77	18.54	2.32	3.09	10.04	2.32	1.55
Smooth Muscle Cells - Bladder, donor1	11519-119H7	13.01	10.01	7.01	8.01	3.00	3.00	1.00	0.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	12.91	8.38	6.52	1.60	7.32	0.80	1.46	1.86	1.60	2.79
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	22.61	4.88	5.98	2.44	9.09	0.22	3.55	2.22	2.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	13.83	10.50	5.25	2.18	14.47	1.28	3.33	8.96	0.77	0.51
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.56	6.19	5.86	5.21	3.26	1.63	1.95	0.00	0.98	0.98
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.83	7.97	7.38	7.38	7.38	2.66	6.20	0.00	2.36	2.95
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	17.23	6.55	6.26	2.70	7.40	0.43	1.71	0.57	1.99	2.70
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.09	0.98	1.14	0.33	0.81	0.33	0.33	0.00	0.65	0.65
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.83	5.48	4.57	2.44	1.52	2.44	0.30	0.30	2.44	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.89	7.83	4.04	1.52	11.37	1.01	0.76	2.78	1.52	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	12.24	12.24	0.00	0.00	24.48	6.12	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	4.29	1.43	0.48	2.38	0.00	0.00	0.95	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.24	11.36	7.23	5.31	5.60	2.06	1.18	0.44	1.03	1.03
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.45	10.76	5.81	3.23	4.52	0.65	0.65	0.65	1.29	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.27	7.14	6.72	4.51	5.25	0.94	1.05	0.94	1.05	2.41
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	9.28	4.64	2.17	0.77	5.10	0.62	1.55	2.17	0.93	1.70
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	16.17	6.47	3.23	0.00	3.23	1.08	1.08	1.08	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	18.23	11.06	9.56	0.90	11.36	1.49	5.08	4.48	1.20	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	2.05	3.41	0.00	1.02	0.00	0.00	0.00	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	11.94	23.87	11.31	6.20	4.08	2.43	2.04	0.94	1.81	1.73
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	49.31	25.06	21.44	2.82	13.69	7.55	3.62	9.26	5.84	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	34.36	14.34	9.78	2.73	30.26	0.46	10.69	9.33	2.28	5.01
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	10.87	12.08	4.83	0.60	10.26	0.00	1.21	12.68	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.97	23.05	13.25	7.95	17.22	3.18	17.22	4.50	2.91	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	25.70	13.85	11.58	3.73	13.18	2.26	2.93	2.66	0.53	1.07
Smooth Muscle Cells - Prostate, donor2	11335-117F3	12.90	4.63	4.13	3.38	2.38	2.13	0.00	0.25	1.13	1.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	13.19	7.61	9.64	3.55	3.55	1.78	0.25	0.00	2.28	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	15.23	9.20	8.14	3.02	10.10	1.96	1.96	1.96	0.90	2.26
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	3.00	4.50	3.00	0.00	6.75	2.25	0.75	0.75	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	12.92	5.17	3.88	0.00	1.29	6.46	1.29	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	25.11	28.37	14.88	2.33	33.02	0.93	6.05	23.25	0.93	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	9.59	6.56	5.55	0.50	13.63	1.01	0.50	2.02	2.02	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	15.04	8.46	2.82	1.88	6.27	1.25	0.31	3.45	1.25	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	6.19	1.18	2.06	0.88	0.29	0.00	0.00	0.00	0.29	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	30.91	17.08	12.91	6.33	18.16	2.17	4.25	3.58	2.33	5.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	23.36	14.95	9.81	1.40	3.27	1.87	0.00	0.00	2.80	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.35	4.61	3.60	1.15	3.60	1.15	1.87	0.43	0.14	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.82	0.76	0.25	1.02	0.25	0.00	0.25	0.51	0.00	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	5.45	2.63	0.38	0.56	0.94	0.19	0.00	0.00	0.19	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	18.45	8.38	7.97	7.55	4.75	1.96	1.26	0.42	1.26	2.79
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.14	7.54	6.70	3.77	3.10	1.34	0.84	0.00	1.17	1.01
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	3.81	4.29	1.43	0.00	1.43	0.00	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.79	3.43	2.20	1.47	1.71	0.49	1.22	0.24	0.73	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.90	13.70	11.49	1.99	10.61	1.55	0.88	1.55	0.22	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	13.46	7.02	3.51	2.93	2.34	2.93	0.88	0.59	0.88	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	33.24	7.39	7.97	3.11	2.72	2.53	0.58	0.00	0.58	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.54	8.73	9.26	1.06	3.97	0.79	0.26	0.79	1.06	0.79
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	28.64	7.44	7.44	5.95	4.84	2.23	1.49	0.37	2.23	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.79	9.70	8.98	1.80	5.39	2.87	0.72	0.00	1.80	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.32	3.41	3.12	1.14	4.54	2.84	1.42	0.00	0.85	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	28.75	6.70	7.48	1.58	7.88	0.79	0.39	0.39	1.18	1.18
Smooth muscle cells - airway, control, donor1	11966-126D4	24.13	8.13	9.14	1.52	1.27	2.29	1.02	0.51	1.02	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	31.95	9.58	6.79	1.20	1.20	4.79	0.00	0.40	2.40	3.19
Smooth muscle cells - airway, control, donor3	11968-126D6	20.90	7.94	8.36	1.25	0.84	2.51	0.42	0.00	1.67	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	16.50	11.00	8.71	2.75	0.92	1.83	0.92	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	12.29	8.75	8.08	3.20	7.41	2.19	2.19	0.84	1.18	0.67
Synoviocyte, donor2	11368-117I9	13.07	10.90	11.06	4.69	8.72	0.84	2.01	1.01	1.17	1.51
Synoviocyte, donor3	11440-118H9	20.55	6.70	10.72	0.89	2.68	2.01	0.45	0.22	1.34	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	12.15	9.29	6.79	0.36	9.65	0.71	0.71	1.07	1.43	2.86
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	5.95	1.98	0.00	3.96	0.00	0.00	1.98	0.00	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	12.04	6.25	3.24	0.93	1.16	0.46	0.23	0.93	0.23	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	2.44	2.51	1.51	2.72	0.00	0.43	0.36	0.07	0.00	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	1.55	1.16	1.16	0.39	0.39	0.00	0.39	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	1.72	1.15	0.57	0.00	0.57	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	12.18	7.14	10.21	4.18	0.86	5.78	0.98	0.12	1.60	1.23
Urethra, donor2	10319-105A4	46.76	35.97	34.17	5.40	3.60	7.19	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	1.33	0.80	0.27	0.27	0.00	0.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	1.60	0.80	1.60	0.40	0.00	0.80	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	1.38	0.92	0.69	0.69	0.00	0.69	0.00	0.00	0.00	0.23
Urothelial cells, donor0	11216-116B1	4.01	6.46	5.80	6.46	0.67	0.45	1.11	0.00	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	37.37	6.23	47.16	4.45	2.67	3.56	3.56	1.78	1.78	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	8.58	37.17	5.72	11.44	4.29	0.00	0.00	0.00	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	20.54	2.05	16.43	5.48	2.74	1.37	2.05	0.68	4.11	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	22.04	5.17	25.83	6.54	6.20	2.75	0.69	0.00	3.10	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.75	6.97	19.17	7.55	4.07	2.91	0.58	0.58	0.58	2.32
Whole blood (ribopure), donor090612, donation1	12182-129A4	38.53	6.25	21.87	3.12	7.29	4.16	0.00	0.00	1.04	3.12
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.04	8.26	30.29	1.84	5.51	3.67	0.92	0.92	1.84	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	22.82	0.00	18.26	0.91	0.00	4.56	0.91	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	6.04	5.55	5.67	4.69	0.37	1.97	0.62	0.00	0.74	1.11
Wilms' tumor cell line:HFWT	10597-108E3	19.36	3.52	7.04	0.88	0.00	2.64	0.00	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	19.83	5.59	5.03	3.63	0.00	2.51	1.12	0.00	1.68	0.84
achilles tendon, donor2	10292-104G4	14.47	2.07	8.27	0.00	4.13	2.07	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	16.83	0.51	0.51	6.88	0.76	3.82	7.14	0.25	1.27	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	8.59	0.70	0.23	13.23	0.00	3.95	1.16	0.00	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	16.74	2.26	3.44	9.97	0.71	4.27	1.31	0.12	1.42	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	10.88	1.36	4.08	10.34	0.54	7.07	1.36	0.00	1.90	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	6.75	1.41	1.97	3.09	0.00	1.97	2.25	0.28	0.00	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5.50	0.85	2.11	4.44	0.21	3.38	0.85	0.00	0.63	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	26.40	2.18	4.63	5.99	0.27	5.17	0.27	0.27	1.09	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	7.93	1.32	2.64	7.49	0.00	1.32	0.00	0.00	0.44	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	16.74	0.41	2.45	2.04	0.00	2.45	0.00	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	17.09	0.39	2.33	6.99	0.39	1.16	0.00	0.00	1.94	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.31	0.18	0.37	1.29	0.00	4.42	0.00	0.00	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	0.00	11.70	3.90	0.00	7.80	0.00	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	7.90	2.32	3.95	4.88	0.00	1.16	2.79	0.00	0.70	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.17	1.29	0.26	4.66	0.26	2.85	0.26	0.00	0.78	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	4.68	0.29	0.29	7.89	0.00	3.80	0.00	0.00	0.58	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	14.87	0.00	0.93	4.18	0.46	4.65	0.00	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.52	2.47	1.65	2.06	0.00	0.41	0.00	0.00	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.06	0.92	0.31	4.60	0.31	1.23	0.00	0.00	0.92	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.40	0.00	1.71	7.68	0.00	2.99	0.00	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	3.03	0.91	1.82	7.89	0.00	2.73	0.00	0.00	1.21	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	3.61	0.72	0.00	7.70	0.24	3.37	0.00	0.00	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	7.57	0.67	0.22	2.67	0.00	2.23	0.00	0.00	0.89	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.69	1.33	0.33	4.34	0.33	5.00	0.33	0.00	2.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	48.31	0.00	1.86	3.72	0.00	20.44	0.00	0.00	3.72	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	15.07	2.26	0.75	6.40	0.00	3.77	0.38	0.00	0.38	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	34.45	1.74	4.80	5.67	0.00	8.29	0.00	0.00	2.62	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	67.48	0.00	13.12	3.75	0.00	9.37	0.00	0.00	5.62	9.37
adenocarcinoma cell line:IM95m	10796-110I4	2.35	0.00	0.24	0.24	0.00	0.47	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	11.32	10.70	13.81	6.67	0.78	7.60	0.31	0.00	1.71	0.47
adipose, donor1	10184-103D4	15.83	36.94	24.63	21.11	6.45	5.86	19.35	0.59	1.17	4.10
adipose, donor2	10185-103D5	10.14	25.55	25.95	6.08	1.62	2.43	5.68	0.41	2.03	1.62
adipose, donor3	10186-103D6	11.71	19.60	14.70	5.72	0.82	2.45	3.54	0.54	2.18	1.91
adipose, donor4	10187-103D7	9.53	10.40	10.40	2.60	2.60	14.73	1.73	0.00	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	25.57	8.05	9.94	9.00	0.00	31.56	0.00	0.16	4.42	2.05
adrenal gland, adult, pool1	10081-102A9	25.46	7.28	7.28	10.91	0.00	0.00	0.00	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	11.87	1.07	1.07	4.40	0.13	3.60	0.00	0.00	0.80	0.40
alveolar cell carcinoma cell line:SW 1573	10708-109H6	20.37	14.65	8.22	2.14	2.50	2.50	6.43	0.71	2.50	1.43
amniotic membrane cells, donor1	12235-129G3	9.04	4.64	12.06	3.94	0.46	9.27	0.23	0.00	1.39	0.70
amniotic membrane cells, donor2	12236-129G4	5.41	3.04	6.09	6.09	0.34	6.42	0.00	0.00	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	5.89	3.83	12.37	5.89	0.00	13.85	0.00	0.00	0.88	0.29
amygdala - adult, donor10196	10167-103B5	28.46	10.67	5.93	4.74	0.00	9.49	0.00	2.37	3.56	1.19
amygdala, adult, donor10252	10151-102I7	22.91	7.50	9.12	6.89	0.81	11.76	1.42	0.41	5.27	2.64
amygdala, newborn, donor10223	10360-105E9	17.11	7.75	5.16	2.90	1.94	6.13	4.20	1.29	3.55	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	29.80	33.23	24.57	5.98	6.75	10.44	1.27	0.38	2.16	1.78
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.13	2.65	1.10	2.65	1.99	1.99	0.66	0.22	0.66	0.88
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	9.69	8.68	7.35	2.00	4.34	1.67	1.67	0.33	1.67	2.34
aorta, adult, pool1	10052-101G7	22.56	12.16	18.04	4.12	0.98	3.92	0.00	0.20	1.96	0.98
appendix, adult	10189-103D9	26.39	12.42	12.03	4.66	0.78	9.70	1.94	0.00	1.55	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.79	4.82	11.69	4.13	0.69	6.53	0.34	0.34	3.78	1.38
artery, adult	10190-103E1	2.72	6.79	4.08	2.72	0.00	1.36	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	17.38	9.27	8.98	6.95	2.32	3.19	1.45	0.58	1.88	1.59
b cell line:RPMI1788	10427-106D4	8.33	0.74	1.19	6.39	0.59	8.18	1.34	0.00	0.59	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	17.76	8.32	9.99	1.39	18.59	0.83	3.61	1.11	2.77	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	17.27	8.04	5.46	6.25	2.68	2.88	4.47	0.30	1.59	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	7.03	0.50	1.34	3.18	0.00	2.34	0.17	0.17	1.00	0.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	7.27	1.68	0.56	7.27	0.00	3.36	0.00	0.00	0.56	0.00
bladder, adult, pool1	10011-101C2	13.58	39.87	38.02	7.93	1.30	5.11	0.33	0.11	0.98	0.87
blood, adult, pool1	10053-101G8	31.00	4.43	8.86	6.64	6.64	0.00	2.21	0.00	4.43	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	59.09	13.70	15.41	1.71	11.99	6.85	2.57	0.00	5.99	5.14
bone marrow, adult	10192-103E3	24.29	11.47	12.15	5.40	2.02	3.37	0.00	0.00	2.02	0.00
brain, adult, donor1	10084-102B3	6.15	9.23	7.18	4.10	1.03	8.20	0.00	0.00	3.08	0.00
brain, adult, pool1	10012-101C3	12.69	10.69	6.90	8.46	1.34	13.14	1.11	0.22	2.78	1.00
brain, fetal, pool1	10085-102B4	5.34	0.00	8.01	0.00	0.00	5.34	0.00	0.00	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	15.20	2.97	2.31	6.61	0.33	15.20	0.00	0.33	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	34.45	6.62	8.61	7.49	0.12	17.60	0.87	0.00	3.50	2.75
breast, adult, donor1	10080-102A8	13.89	10.73	18.31	5.68	0.00	3.16	0.63	0.00	0.63	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	4.95	1.78	2.16	4.32	0.00	1.27	0.00	0.25	1.02	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	22.26	2.16	8.66	4.64	0.62	2.47	2.47	0.00	2.47	1.86
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	10.13	8.29	12.43	5.99	1.84	7.37	0.23	0.23	1.38	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	16.22	0.48	0.97	5.33	0.24	7.26	1.45	0.24	1.94	0.73
carcinoid cell line:NCI-H1770	10703-109H1	5.64	6.58	8.46	12.69	0.00	8.93	0.94	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	25.16	7.11	8.31	4.16	0.55	6.13	1.86	0.22	2.41	2.63
carcinoid cell line:SK-PN-DW	10719-109I8	21.23	17.11	9.82	4.75	1.27	2.54	0.63	0.32	1.58	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	38.60	33.54	17.04	13.84	0.53	20.76	2.93	1.33	5.86	2.66
caudate nucleus - adult, donor10196	10177-103C6	36.84	3.45	6.91	3.45	3.45	14.97	10.36	1.15	1.15	4.61
caudate nucleus, adult, donor10252	10164-103B2	21.08	10.88	7.70	5.52	2.84	6.19	12.05	0.67	4.69	2.18
caudate nucleus, adult, donor10258	10379-105H1	20.63	7.64	9.17	8.41	2.29	8.41	9.93	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	18.68	13.55	8.42	4.76	3.30	6.59	3.66	0.00	1.10	0.00
cerebellum - adult, donor10196	10173-103C2	34.96	32.05	23.31	2.91	0.00	37.87	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	26.48	29.89	24.98	7.69	0.85	43.98	1.49	0.00	7.05	1.28
cerebellum, adult, pool1	10083-102B2	15.52	18.28	19.66	4.48	0.34	10.00	0.34	0.34	2.76	0.34
cerebellum, newborn, donor10223	10357-105E6	25.74	30.72	28.23	5.81	1.66	28.23	4.98	0.83	3.32	0.83
cerebral meninges, adult	10188-103D8	13.62	8.57	6.56	8.07	0.00	9.83	0.00	0.00	1.51	1.01
cerebrospinal fluid, donor2	10294-104G6	8.04	4.39	8.77	0.00	0.00	4.39	0.00	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	2.88	3.16	2.44	3.88	0.29	5.90	0.58	0.29	0.29	0.00
cervical cancer cell line:ME-180	10553-107I4	16.24	3.65	4.47	7.62	2.15	4.64	2.82	0.00	2.98	1.49
cervix, adult, pool1	10013-101C4	21.52	32.23	38.74	9.13	2.10	9.13	0.94	0.10	1.78	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	54.34	21.04	16.16	10.73	4.04	5.43	1.95	0.98	4.88	4.74
chondrosarcoma cell line:SW 1353	10700-109G7	65.31	39.19	20.90	3.92	2.61	5.23	6.53	0.00	2.61	6.53
choriocarcinoma cell line:BeWo	10423-106C9	11.81	21.13	20.13	10.81	1.37	4.23	7.95	0.25	1.12	1.49
choriocarcinoma cell line:SCH	10785-110H2	3.82	3.82	2.34	4.19	0.00	3.82	0.25	0.12	0.99	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	12.81	6.64	6.40	4.51	0.47	9.01	0.00	0.24	2.13	1.19
chorionic membrane cells, donor1	12238-129G6	7.98	4.84	6.84	5.70	1.42	1.71	1.42	0.00	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	14.62	8.35	6.56	3.48	7.26	1.59	4.87	0.60	1.29	3.18
chorionic membrane cells, donor3	12240-129G8	7.69	7.14	2.75	5.49	1.10	1.10	0.00	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	2.02	1.01	0.00	1.01	0.00	2.02	1.01	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	13.06	2.11	1.73	4.61	0.58	0.38	1.92	0.19	1.34	2.31
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	14.78	0.63	1.90	4.65	0.00	3.38	0.42	0.00	1.06	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	19.52	6.68	3.34	9.76	0.00	10.53	0.00	0.26	2.05	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	22.74	5.08	3.87	12.34	0.48	9.68	0.00	0.00	0.97	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	21.18	6.31	4.07	11.40	0.20	10.99	1.02	0.20	2.24	1.63
chronic myelogenous leukemia cell line:K562	10454-106G4	11.19	4.42	4.71	13.84	0.00	5.89	0.59	0.00	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	17.72	3.91	4.69	10.16	0.00	5.21	0.26	0.00	1.30	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	4.11	6.86	5.94	1.60	0.00	1.60	0.69	0.46	0.91	0.46
clear cell carcinoma cell line:TEN	10636-108I6	3.64	3.12	2.95	5.03	0.52	5.03	0.17	0.17	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	8.79	11.17	12.26	6.04	0.55	1.10	2.20	0.00	0.92	1.83
colon carcinoma cell line:COLO-320	10420-106C6	42.19	30.79	21.28	17.10	3.42	12.16	9.12	0.76	4.94	4.18
colon, adult, donor1	10082-102B1	9.52	8.33	9.52	2.38	0.00	2.38	0.00	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	13.87	18.33	20.68	4.82	0.94	4.58	0.35	0.24	2.00	0.71
colon, fetal, donor1	10070-101I7	35.23	37.08	32.75	4.94	1.24	5.56	0.62	0.00	3.09	1.85
common myeloid progenitor CMP, donor1	12130-128D6	41.25	0.00	9.17	4.58	0.00	0.00	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	9.77	2.97	2.55	4.67	4.25	5.52	0.00	0.00	2.55	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	9.96	2.11	1.96	5.58	11.17	3.92	1.06	0.00	1.81	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	14.10	2.68	1.41	4.51	10.86	5.92	0.56	0.14	1.41	0.71
corpus callosum, adult, pool1	10042-101F6	15.70	8.51	5.53	4.31	0.00	9.40	0.22	0.00	2.32	0.88
cruciate ligament, donor2	10295-104G7	22.69	5.67	26.75	1.62	0.00	3.24	0.00	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	12.04	11.24	4.82	0.80	3.21	0.00	0.00	1.61	0.80
diencephalon, adult	10193-103E4	12.48	7.68	6.24	2.40	0.72	8.16	0.72	0.00	3.84	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	23.42	2.07	1.15	7.58	0.92	9.41	2.30	0.00	2.30	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	22.82	3.59	3.85	8.46	0.51	12.05	1.54	0.00	3.08	1.54
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	9.63	13.48	11.55	13.96	0.48	1.93	1.44	0.24	2.65	1.20
ductus deferens, adult	10196-103E7	29.40	17.44	20.93	3.99	1.00	5.48	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	41.77	11.52	17.28	12.96	0.00	2.88	1.44	0.00	2.88	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	27.95	8.83	7.36	4.41	0.74	7.36	0.00	0.00	3.68	2.21
dura mater, adult, donor1	10041-101F5	13.71	8.59	10.57	7.52	0.91	5.62	0.25	0.17	1.40	1.24
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	7.55	6.22	4.44	3.33	5.33	5.55	0.67	5.11	1.55	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.35	15.76	8.02	10.03	10.32	4.59	3.01	15.05	2.58	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	27.13	18.50	19.73	1.23	6.78	3.08	6.17	1.85	4.32	2.47
embryonic pancreas cell line:1C3D3	10605-108F2	17.25	46.92	19.68	1.82	24.82	2.72	16.65	10.90	1.51	3.33
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.04	18.22	19.14	1.85	5.56	5.25	7.41	1.85	2.78	3.40
embryonic pancreas cell line:2C6	10603-108E9	52.54	22.33	23.64	0.00	11.82	3.94	11.82	0.00	3.94	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	6.37	9.05	7.04	4.69	0.00	1.68	1.34	0.00	1.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	7.43	6.16	10.69	3.44	1.45	5.98	0.54	0.00	1.27	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	8.20	1.77	1.77	3.06	0.16	5.31	0.00	0.16	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	13.01	2.33	2.45	4.67	0.11	3.78	1.89	0.00	1.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	16.17	6.16	5.06	9.57	0.66	3.85	6.49	0.00	1.21	1.87
epididymis, adult	10197-103E8	37.26	31.19	34.54	6.70	4.81	7.95	2.93	0.84	3.14	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	10.47	21.29	16.68	7.98	1.42	2.48	0.53	0.35	0.18	1.24
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.15	15.73	2.75	4.33	6.69	0.39	17.30	4.72	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	9.17	2.62	2.88	4.98	0.52	14.81	3.54	0.26	1.97	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	12.79	3.84	2.76	6.99	0.30	15.55	3.05	0.00	2.66	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	11.31	1.46	2.69	5.27	0.56	14.56	2.58	0.00	2.58	0.90
esophagus, adult, pool1	10015-101C6	17.41	16.88	21.45	8.92	0.42	7.54	1.70	0.00	2.12	1.49
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	25.80	21.67	17.41	11.77	1.63	5.39	0.25	0.25	2.38	3.88
eye - muscle inferior rectus, donor1	10272-104E2	31.39	21.73	4.83	0.00	0.00	0.00	0.00	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	4.21	8.42	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	8.93	5.95	0.00	2.98	2.98	1.49	0.00	1.49	0.00
eye - muscle superior, donor2	10297-104G9	17.20	11.46	12.61	1.15	1.15	1.15	0.00	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	17.49	1.46	0.00	1.46	0.00	1.46	1.46	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	17.54	15.76	16.53	3.31	0.00	8.90	0.76	0.25	3.05	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	24.23	11.54	7.82	3.33	7.31	1.15	3.59	1.67	1.54	4.23
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.67	7.60	5.70	2.14	0.95	3.32	0.24	0.00	0.95	3.32
frontal lobe, adult, pool1	10040-101F4	16.98	9.95	7.41	11.92	1.78	12.76	2.81	0.38	2.72	1.69
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	16.81	6.61	6.31	9.91	0.30	5.40	0.90	0.30	2.40	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	12.07	20.30	17.56	4.85	1.65	3.20	1.83	0.73	0.91	1.65
gall bladder, adult	10198-103E9	12.55	11.59	12.55	4.35	0.48	3.14	0.24	0.00	0.97	0.24
gamma delta positive T cells, donor1	11937-126A2	32.21	2.68	3.76	5.91	9.13	1.61	4.29	0.00	1.07	0.54
gamma delta positive T cells, donor2	11938-126A3	29.13	1.87	5.23	3.36	5.60	4.11	1.49	0.37	0.37	2.24
gastric adenocarcinoma cell line:MKN1	10614-108G2	19.22	4.22	2.75	4.22	3.38	4.01	2.53	0.21	2.53	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	14.51	2.71	4.06	4.06	0.19	3.48	1.74	0.00	1.55	0.97
gastric cancer cell line:AZ521	10549-107H9	12.30	8.85	9.51	8.53	1.31	7.71	2.13	0.33	2.79	1.15
gastric cancer cell line:GSS	10560-108A2	13.73	5.49	25.63	1.83	0.00	13.73	0.00	0.92	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	14.16	9.82	6.63	1.37	0.69	6.17	3.20	0.00	2.28	1.14
giant cell carcinoma cell line:LU65	10487-107B1	7.00	1.26	1.03	7.00	0.00	5.28	0.92	0.11	0.69	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	13.72	30.79	25.33	6.16	3.08	1.26	6.86	0.70	0.42	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	12.97	3.49	1.75	2.49	0.25	3.49	0.00	0.00	1.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	16.04	9.71	5.49	2.64	7.49	3.59	20.69	1.69	0.84	1.06
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.05	10.39	5.20	2.11	8.71	4.35	13.06	1.12	1.83	2.81
glioblastoma cell line:T98G	10485-107A8	31.46	25.61	14.79	9.05	15.56	2.76	4.64	1.55	2.98	3.97
glioma cell line:GI-1	10413-106B8	14.06	18.16	7.91	9.08	1.76	3.81	2.05	0.29	1.17	3.22
globus pallidus - adult, donor10196	10175-103C4	26.24	5.10	8.75	3.64	0.00	8.75	0.73	0.00	4.37	0.73
globus pallidus, adult, donor10252	10161-103A8	20.99	7.81	7.08	5.37	0.24	14.40	0.98	0.00	2.44	0.49
globus pallidus, adult, donor10258	10367-105F7	12.32	10.95	10.95	4.11	0.00	2.74	0.00	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	12.79	6.40	3.73	3.20	1.07	3.20	0.00	0.00	1.60	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	26.92	2.45	0.00	2.45	4.89	7.34	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	10.45	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	27.52	7.36	10.24	2.56	2.88	1.28	0.96	0.32	1.28	0.96
hIPS +CCl2, biol_rep1	14383-156B9	26.63	16.07	11.48	4.13	1.38	13.31	2.75	0.46	0.46	5.51
hIPS +CCl2, biol_rep2	14384-156C1	26.06	10.52	10.06	2.29	1.83	13.26	2.74	0.00	2.29	2.29
hIPS +CCl2, biol_rep3	14385-156C2	28.34	6.44	9.66	1.29	0.64	9.66	2.58	0.00	0.64	3.22
hIPS, biol_rep1	14380-156B6	44.56	4.31	25.87	1.44	0.00	18.68	0.00	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	24.69	2.74	13.72	2.06	2.74	8.23	2.06	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	23.17	9.93	7.72	5.52	1.10	7.72	0.00	1.10	1.10	2.21
hairy cell leukemia cell line:Mo	10712-109I1	10.06	0.57	0.86	4.88	0.57	4.60	0.29	0.00	1.44	0.29
heart - mitral valve, adult	10205-103F7	23.32	18.54	13.45	5.08	7.47	5.98	0.60	1.20	1.49	1.79
heart - pulmonic valve, adult	10206-103F8	10.46	12.29	13.60	2.35	0.00	6.28	0.26	0.26	1.05	1.05
heart - tricuspid valve, adult	10207-103F9	32.47	14.99	14.15	1.67	3.33	10.82	0.83	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	7.55	1.84	4.90	2.24	0.41	1.63	0.00	0.00	0.82	0.41
heart, adult, diseased, donor1	10051-101G6	7.24	6.81	4.26	0.85	0.00	1.28	0.43	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	11.04	11.73	12.19	2.07	2.07	3.22	0.00	0.00	0.46	1.61
heart, fetal, pool1	10046-101G1	13.04	11.91	10.88	4.11	1.03	5.13	1.64	0.10	1.54	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	21.60	8.02	7.10	2.47	3.70	2.16	0.00	0.31	2.16	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	11.89	8.32	10.70	4.76	2.38	2.38	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	12.15	4.53	5.19	4.86	1.66	2.98	2.76	0.22	2.21	1.99
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	11.65	5.83	5.46	4.01	2.06	2.79	2.06	0.12	1.82	1.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	9.09	5.76	6.06	5.86	1.52	2.93	3.54	0.40	2.32	2.32
hepatoma cell line:Li-7	10484-107A7	12.23	5.45	6.12	5.12	1.00	1.78	3.23	0.11	1.00	1.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.42	1.21	1.41	4.32	0.10	1.51	0.90	0.20	1.01	0.50
hippocampus - adult, donor10196	10169-103B7	39.75	3.79	8.52	4.73	1.89	7.57	0.00	0.00	3.79	3.79
hippocampus, adult, donor10252	10153-102I9	26.94	10.20	8.57	4.29	0.82	17.76	1.02	0.00	5.92	0.61
hippocampus, adult, donor10258	10374-105G5	30.87	3.49	9.46	2.49	0.00	9.96	0.50	0.00	1.00	0.00
hippocampus, newborn, donor10223	10363-105F3	15.16	8.11	4.58	2.82	0.70	4.58	2.47	0.35	0.70	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.88	18.92	14.04	10.99	0.61	5.49	3.66	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.50	7.07	7.66	6.28	0.00	2.36	1.18	0.20	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	7.62	11.43	7.87	5.59	1.02	4.57	0.51	0.00	0.25	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	8.46	33.27	19.74	5.07	1.13	2.82	4.51	0.56	1.13	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	10.59	57.84	39.76	10.84	2.32	1.81	7.23	1.03	1.03	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	6.45	34.92	23.54	8.73	2.66	2.28	4.18	0.00	1.90	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	10.51	14.89	14.31	7.01	0.58	5.84	2.04	0.88	1.75	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.62	19.82	15.94	10.99	0.86	1.29	2.80	0.43	0.86	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	10.01	17.52	15.85	7.09	0.83	3.34	2.50	0.00	1.25	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	9.23	8.52	6.87	7.81	0.47	3.55	2.84	0.47	0.24	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	11.57	9.96	8.52	7.23	0.96	1.45	1.45	0.48	0.64	1.45
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	8.08	13.47	5.39	2.02	5.39	1.35	0.00	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	6.73	12.99	8.29	4.85	0.63	3.76	1.10	0.63	1.41	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	8.35	13.26	8.84	7.86	0.00	2.95	2.95	0.98	0.98	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	19.20	10.47	1.75	0.87	6.11	1.75	0.87	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	13.55	43.72	32.84	12.79	3.25	2.86	7.45	0.57	2.29	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	17.88	37.50	28.78	5.67	0.00	2.18	4.36	0.87	0.44	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	15.99	47.48	32.48	15.99	2.50	6.00	6.00	2.00	2.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.52	29.20	29.20	9.23	1.51	2.07	10.17	1.13	0.38	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	7.28	36.83	33.65	8.64	0.91	2.73	10.46	0.45	0.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	9.71	23.49	24.75	5.33	0.94	0.94	5.95	0.00	0.31	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	12.90	15.19	15.19	5.55	0.98	3.59	4.41	0.16	0.98	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	8.42	12.77	13.35	4.94	0.58	4.94	5.23	0.58	2.61	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	17.04	13.15	13.15	4.78	0.90	4.78	2.09	0.30	0.90	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	3.88	10.16	9.79	5.73	0.74	1.11	1.11	0.55	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.99	12.84	9.13	3.71	0.86	3.71	2.00	0.86	0.86	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	5.31	8.57	8.98	7.35	0.82	3.27	2.45	0.82	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	9.15	21.48	21.83	7.04	1.06	2.11	7.75	0.35	0.35	0.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	5.07	16.15	16.15	5.07	1.90	1.90	5.70	0.32	0.00	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.87	16.95	15.13	6.96	1.21	2.12	4.54	0.61	0.91	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	8.27	10.34	13.96	5.17	1.55	3.62	4.65	1.03	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	8.63	9.30	11.29	1.33	0.66	3.32	4.65	0.66	0.00	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	4.36	6.16	3.85	4.87	0.51	2.31	1.03	0.00	0.51	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.95	5.62	9.20	3.58	1.28	2.05	1.53	0.51	0.51	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	8.33	14.39	10.60	2.27	0.76	0.76	3.79	0.76	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	14.45	14.79	9.07	6.72	0.67	3.02	1.01	0.00	1.01	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.11	11.35	7.73	7.25	0.48	2.90	1.69	0.00	0.72	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.47	12.48	10.70	4.46	0.45	4.01	0.45	0.89	0.89	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.80	9.27	8.29	6.34	1.46	4.88	1.95	0.00	0.49	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.39	29.64	22.00	8.86	3.67	2.44	7.33	0.61	1.53	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	26.03	100.85	42.29	48.80	19.52	3.25	78.08	9.76	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	13.24	46.00	37.07	11.91	2.98	2.32	10.92	1.32	0.99	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.66	21.89	13.68	4.38	1.09	1.64	4.38	0.55	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.13	14.48	10.86	6.15	0.72	2.53	2.90	0.00	0.72	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.25	17.08	14.59	4.63	1.42	1.42	3.20	0.36	1.07	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	14.32	20.29	11.93	5.97	1.19	1.19	4.77	0.00	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	15.17	16.25	15.84	9.07	0.68	2.17	4.20	0.27	2.17	3.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	11.58	9.16	7.81	4.31	0.27	0.81	0.81	0.27	1.35	1.62
immature langerhans cells, donor1	11904-125F5	3.39	0.24	0.24	2.42	0.24	6.30	0.00	0.00	0.73	0.00
immature langerhans cells, donor2	11905-125F6	2.38	0.00	0.00	2.38	0.79	3.96	0.00	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	17.70	6.72	5.20	7.48	1.23	13.34	0.66	0.19	2.46	1.42
keratoacanthoma cell line:HKA-1	10791-110H8	12.68	1.95	0.65	4.23	0.00	2.28	0.00	0.00	2.28	1.30
kidney, adult, pool1	10017-101C8	11.21	7.61	10.11	4.01	1.30	6.11	0.60	0.10	1.90	0.70
kidney, fetal, pool1	10045-101F9	10.19	4.46	5.38	2.19	0.42	5.73	0.50	0.00	1.27	1.56
large cell lung carcinoma cell line:IA-LM	10509-107D5	51.98	140.17	97.57	15.91	12.92	3.98	6.67	3.83	6.11	14.63
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.19	2.35	1.52	2.63	0.28	2.35	0.69	0.14	0.41	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	33.21	34.13	31.93	4.04	5.14	1.65	13.95	0.55	1.83	3.12
left atrium, adult, donor1	10079-102A7	14.71	16.89	15.80	2.72	0.54	2.18	0.54	0.00	1.63	1.09
left ventricle, adult, donor1	10078-102A6	14.16	13.65	4.55	2.53	1.52	0.51	0.51	0.51	1.52	1.01
leiomyoblastoma cell line:G-402	10721-110A1	12.86	4.92	3.83	3.83	0.27	3.01	0.55	0.00	2.46	0.82
leiomyoma cell line:10964C	10569-108B2	8.26	3.59	3.59	1.80	6.11	2.51	1.08	0.72	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	6.52	5.98	2.17	0.54	5.43	0.00	0.54	1.09	1.63	0.54
leiomyoma cell line:15425	10571-108B4	6.80	3.64	3.89	1.46	2.43	1.21	0.24	0.73	1.21	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	6.35	0.00	0.00	12.70	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	14.64	18.82	1.05	2.09	24.05	0.00	1.05	3.14	3.14
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	10.86	1.65	1.18	3.78	0.59	0.83	1.06	0.00	1.06	1.65
liposarcoma cell line:KMLS-1	10782-110G8	24.52	15.15	13.59	2.50	8.90	1.25	1.25	0.78	0.94	2.50
liposarcoma cell line:SW 872	10726-110A6	21.93	10.84	9.50	5.12	1.58	2.56	0.24	0.49	2.56	2.07
liver, adult, pool1	10018-101C9	11.83	3.73	4.70	5.19	1.46	4.54	0.49	0.00	1.62	0.32
liver, fetal, pool1	10086-102B5	8.47	3.76	9.41	0.00	0.94	1.88	1.88	0.94	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	19.83	14.44	10.50	2.77	0.29	12.54	0.58	0.00	3.50	0.87
locus coeruleus, adult, donor10252	10165-103B3	16.06	12.36	9.23	4.61	0.37	13.29	0.74	0.18	4.43	0.74
locus coeruleus, adult, donor10258	10375-105G6	13.82	10.44	11.29	5.92	1.13	4.51	0.28	0.28	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	25.66	15.98	7.57	7.15	0.42	15.98	0.84	0.42	1.68	0.84
lung adenocarcinoma cell line:A549	10499-107C4	11.49	7.61	7.61	5.81	0.69	3.46	0.83	0.14	2.21	1.38
lung adenocarcinoma cell line:PC-14	10408-106B3	100.65	6.89	17.24	7.58	1.38	51.02	4.14	0.00	5.52	7.58
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	28.47	8.96	14.76	5.40	0.79	1.98	1.32	0.53	2.37	1.58
lung, adult, pool1	10019-101D1	12.29	10.16	14.41	6.26	2.01	6.38	1.65	0.24	0.95	0.59
lung, fetal, donor1	10068-101I5	41.10	25.12	38.82	5.99	2.57	21.69	1.71	0.29	2.00	0.86
lung, right lower lobe, adult, donor1	10075-102A3	32.08	10.08	20.16	5.50	1.83	4.12	0.46	0.00	1.37	1.37
lymph node, adult, donor1	10077-102A5	22.25	5.21	6.15	3.31	4.26	2.37	1.89	1.42	2.84	1.42
lymphangiectasia cell line:DS-1	10727-110A7	20.38	2.19	1.10	5.48	0.88	3.73	0.66	0.22	1.53	1.53
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	8.00	0.15	0.60	3.77	1.66	9.81	5.74	0.15	1.36	1.06
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	29.73	3.40	3.40	3.40	3.40	8.49	1.70	0.00	6.80	0.85
mature adipocyte, donor1	12231-129F8	5.33	1.33	8.44	3.55	0.44	4.88	0.00	0.00	2.22	0.00
mature adipocyte, donor2	12232-129F9	8.09	4.57	9.13	3.94	0.21	6.23	0.42	0.21	1.45	0.00
mature adipocyte, donor3	12233-129G1	4.98	4.27	4.98	4.27	0.24	7.59	0.24	0.00	1.19	0.24
mature adipocyte, donor4	12234-129G2	8.69	3.95	6.84	4.74	0.26	10.53	0.00	0.00	2.63	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	106.26	15.73	31.69	9.29	0.95	31.69	1.19	0.48	16.20	15.25
medial frontal gyrus - adult, donor10196	10170-103B8	30.46	11.28	9.02	4.51	3.38	10.15	1.13	0.00	3.38	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	22.99	11.03	9.75	3.86	1.29	14.34	1.47	0.18	5.15	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	22.24	9.53	7.31	2.54	3.18	11.12	1.27	0.00	3.18	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	11.09	5.97	8.53	3.84	11.94	4.69	1.28	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	33.75	17.21	17.89	11.31	3.04	18.23	1.86	0.34	3.71	1.86
medial temporal gyrus, adult, donor10252	10156-103A3	32.47	10.61	8.91	4.88	1.70	15.92	1.27	0.21	4.03	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	53.94	5.78	1.93	1.93	0.00	5.78	3.85	0.00	5.78	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	71.77	28.71	57.41	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	14.36	9.69	5.38	3.23	0.72	8.26	0.72	0.36	1.44	1.44
medulla oblongata - adult, donor10196	10174-103C3	27.91	9.73	11.03	3.24	1.30	7.79	0.00	0.00	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	16.10	10.06	7.89	3.25	0.77	18.42	0.15	0.15	3.25	0.46
medulla oblongata, adult, pool1	10038-101F2	9.63	5.96	5.55	4.41	0.57	10.86	0.16	0.00	2.12	0.82
medulla oblongata, newborn, donor10223	10361-105F1	17.01	9.37	8.68	3.12	0.69	16.32	0.69	0.00	1.74	0.35
medulloblastoma cell line:D283 Med	10838-111E1	7.75	6.20	5.31	4.65	0.44	7.31	1.99	0.44	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	13.69	10.88	5.38	3.42	1.22	2.57	0.37	0.61	2.08	2.45
melanoma cell line:COLO 679	10514-107E1	21.85	5.75	4.31	4.02	2.30	0.29	5.46	0.72	1.87	2.59
melanoma cell line:G-361	10465-106H6	16.02	1.63	1.63	3.80	0.00	2.17	0.27	0.00	1.09	0.00
meningioma cell line:HKBMM	10691-109F7	32.20	53.37	24.78	5.43	51.56	1.09	45.59	23.16	2.71	2.17
merkel cell carcinoma cell line:MKL-1	10843-111E6	15.86	12.34	25.55	9.69	0.00	12.34	0.00	0.88	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	6.48	14.00	17.89	5.96	0.26	2.59	1.81	0.00	1.56	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.05	5.68	4.45	2.76	5.98	1.07	1.07	0.46	1.69	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	6.54	4.00	3.45	1.82	1.27	0.91	0.18	0.18	0.73	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	11.18	2.90	2.48	1.24	4.14	1.66	1.66	0.00	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	6.88	5.48	4.78	2.95	6.74	0.84	1.26	0.56	0.84	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	10.78	4.43	4.43	2.70	5.01	0.77	1.54	0.39	1.54	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	16.66	4.86	7.63	2.78	6.94	2.08	0.00	0.69	2.78	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	8.41	4.29	4.46	1.54	2.23	0.51	0.34	0.34	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.62	3.68	3.11	2.65	2.42	1.38	0.92	0.12	0.81	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.46	6.76	5.70	2.25	5.97	1.86	2.39	2.12	1.06	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.21	3.92	2.70	5.67	4.73	1.08	2.97	1.08	0.54	1.22
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	13.51	5.98	5.12	3.56	4.55	1.00	5.41	0.57	1.42	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	11.20	2.96	5.27	0.66	2.63	1.65	0.66	0.66	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	12.59	4.43	2.63	3.74	3.18	1.38	4.01	0.42	1.38	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	14.66	10.47	7.33	3.84	4.89	1.75	1.75	1.75	2.44	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	3.67	3.06	4.90	2.04	1.84	0.82	0.82	0.20	0.41	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.63	2.88	4.67	2.16	3.59	1.08	6.47	1.08	1.44	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.38	10.55	9.41	2.07	10.97	1.34	10.86	7.86	1.03	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	15.05	7.52	7.07	0.68	15.28	2.05	13.00	12.54	1.14	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	10.07	12.17	5.87	3.78	5.03	2.10	5.45	5.87	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	13.30	3.59	2.99	2.54	3.44	1.05	2.09	0.60	1.34	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.69	9.02	7.53	4.03	3.85	1.84	3.68	1.40	1.58	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	14.73	9.94	6.26	2.21	2.58	2.58	0.37	1.10	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.45	3.72	3.43	2.58	5.15	0.86	9.44	1.43	0.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	15.16	3.79	2.11	2.11	4.63	2.53	2.11	0.42	0.84	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	6.39	4.57	0.91	1.37	0.91	0.00	0.00	1.37	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	6.65	4.86	4.09	3.84	2.30	0.00	0.77	1.02	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.87	8.90	3.40	2.62	1.31	1.83	0.00	0.52	1.05	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.47	5.55	5.85	5.24	3.08	3.70	0.00	0.00	2.46	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.88	6.35	5.65	2.59	2.59	3.29	0.47	0.00	0.71	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.51	4.74	3.38	2.37	2.03	2.71	1.02	0.00	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	8.65	4.72	7.07	2.75	2.36	2.36	0.39	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.88	6.02	6.95	2.78	4.63	3.24	0.00	0.00	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	15.29	8.36	7.50	3.17	2.88	3.17	0.58	0.29	2.02	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.72	4.69	5.13	5.13	2.23	2.68	0.00	0.45	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.42	4.09	6.97	3.36	2.88	2.64	0.72	0.00	0.24	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.93	7.33	10.27	3.67	4.40	2.20	0.00	0.00	3.67	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	9.73	7.05	4.70	1.68	2.69	2.69	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	10.23	5.32	3.68	4.91	3.68	1.64	0.00	0.00	1.23	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.89	8.16	3.44	2.58	2.15	3.01	0.00	0.00	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	2.73	5.47	2.73	5.47	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	0.00	5.16	0.00	0.00	0.00	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	15.26	4.55	5.52	2.92	1.62	1.30	0.00	0.00	0.00	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	5.82	5.82	4.36	4.36	1.45	0.00	2.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	8.00	6.40	3.20	1.60	3.20	0.53	0.00	0.53	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	13.08	4.91	5.72	0.82	2.45	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.66	6.61	5.05	3.11	2.72	1.55	0.78	0.00	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	6.30	12.59	2.10	2.10	4.20	2.10	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	7.95	7.95	0.99	2.98	1.99	0.99	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	9.53	9.53	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	7.12	8.89	1.78	4.15	3.56	0.00	0.00	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	9.75	6.09	3.66	0.00	4.87	1.22	0.00	0.00	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	6.33	6.33	2.53	1.90	1.27	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	38.28	15.18	11.73	2.07	11.04	2.76	0.00	2.76	1.38	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	17.19	15.04	6.45	21.49	0.00	2.15	8.60	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	27.94	3.99	0.00	19.96	3.99	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	24.11	20.66	0.00	37.88	0.00	0.00	0.00	3.44	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	23.63	17.52	12.63	1.63	13.45	2.04	2.44	2.04	1.22	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	39.72	22.24	18.27	3.97	15.09	2.38	1.59	1.59	0.79	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	40.68	25.94	13.56	1.77	24.76	0.59	2.95	1.18	1.77	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	37.40	22.44	10.91	3.12	15.59	2.18	5.61	1.25	2.49	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	30.74	26.73	16.04	2.67	25.40	2.67	5.35	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	5.91	3.55	1.18	10.64	2.37	1.18	1.18	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	20.54	15.41	7.70	2.57	12.84	0.00	5.14	5.14	5.14	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	22.72	6.88	6.88	0.69	11.01	2.07	2.07	0.00	0.69	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	6.43	1.98	3.46	3.46	2.47	1.48	1.48	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	11.22	1.12	1.12	1.12	0.00	2.24	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	8.27	1.91	3.82	3.82	0.00	1.27	0.00	0.00	0.00	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.84	0.40	0.81	0.81	0.40	0.40	0.00	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	0.00	0.00	2.18	0.00	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	2.53	2.53	2.53	0.00	3.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.03	0.61	3.03	0.61	0.00	2.43	0.00	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52	0.00	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	0.82	0.82	4.94	0.00	1.65	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.14	3.37	5.95	1.98	0.79	1.19	0.00	0.00	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.54	2.60	1.95	1.95	0.32	2.27	0.32	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	2.04	4.07	1.02	0.00	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	5.42	8.51	3.09	7.74	6.19	6.96	0.00	4.64	3.09
mesothelioma cell line:ACC-MESO-1	10493-107B7	17.95	56.70	43.00	4.02	6.61	6.61	6.61	2.83	1.18	1.42
mesothelioma cell line:ACC-MESO-4	10494-107B8	17.38	11.58	15.29	6.72	1.39	3.94	1.39	0.46	1.85	1.85
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	17.09	8.55	4.27	4.27	0.00	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	41.20	40.28	18.08	5.14	21.37	1.95	6.47	3.80	4.01	4.01
mesothelioma cell line:Mero-25	10850-111F4	4.99	9.53	7.26	0.91	0.91	0.45	8.40	0.68	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	31.78	14.67	12.71	4.89	17.60	1.22	20.54	2.69	2.44	1.22
mesothelioma cell line:Mero-48a	10852-111F6	25.02	18.16	14.61	2.66	11.07	3.76	9.30	1.33	1.33	2.66
mesothelioma cell line:Mero-82	10853-111F7	19.97	12.61	6.31	3.68	5.52	0.79	8.94	1.84	1.58	2.37
mesothelioma cell line:Mero-83	10854-111F8	28.94	39.15	13.79	3.06	34.73	0.34	52.09	6.98	1.87	3.74
mesothelioma cell line:Mero-84	10855-111F9	5.31	6.32	4.80	1.26	4.55	0.76	3.03	1.26	1.01	0.25
mesothelioma cell line:Mero-95	10856-111G1	13.87	16.36	9.32	1.86	6.63	1.45	10.77	1.04	0.62	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	23.85	29.15	14.91	1.82	20.21	3.31	10.77	6.29	1.49	1.49
mesothelioma cell line:NCI-H226	10846-111E9	17.56	20.45	13.94	1.81	11.04	0.90	1.99	6.15	0.54	1.99
mesothelioma cell line:NCI-H2452	10848-111F2	21.87	12.98	14.18	5.98	2.39	4.27	2.05	1.20	2.73	2.56
mesothelioma cell line:NCI-H28	10845-111E8	7.89	4.58	4.83	5.09	0.25	5.85	0.76	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	23.16	27.73	10.44	5.22	5.22	0.98	12.07	1.63	0.00	1.63
mesothelioma cell line:ONE58	10858-111G3	30.89	32.51	11.65	2.17	21.68	1.08	5.15	5.69	1.35	1.08
migratory langerhans cells, donor1	11901-125F2	9.21	0.38	0.96	2.11	0.77	5.95	0.38	0.00	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	6.23	0.61	0.85	2.81	0.00	3.66	0.49	0.00	0.49	0.12
migratory langerhans cells, donor3	11903-125F4	7.00	0.36	1.62	4.13	0.00	7.36	0.36	0.00	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	15.67	16.98	12.73	3.92	1.31	1.96	0.65	0.98	1.63	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	7.84	4.66	3.60	1.27	1.91	0.64	0.64	4.03	1.06	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	38.93	4.38	5.53	3.46	0.92	0.69	3.69	0.23	1.38	3.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.80	0.95	0.76	2.47	1.71	0.19	0.19	0.19	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	7.95	2.40	1.29	13.31	0.18	3.88	0.18	0.18	0.18	0.00
myeloma cell line:PCM6	10474-106I6	11.66	1.58	1.58	5.93	0.59	1.58	0.59	0.20	1.19	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	141.03	41.60	29.42	1.52	36.02	5.58	19.78	1.52	8.62	8.62
myxofibrosarcoma cell line:NMFH-1	10684-109E9	25.69	2.75	3.33	1.57	0.59	4.51	0.00	0.00	1.96	1.57
nasal epithelial cells, donor1, tech_rep1	12226-129F3	3.45	1.78	1.11	3.23	0.00	2.90	0.22	0.00	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	3.38	0.66	1.32	4.85	0.00	2.13	0.15	0.00	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	2.76	3.31	1.66	5.52	0.00	6.62	1.66	0.00	1.66	0.55
neuroblastoma cell line:CHP-134	10508-107D4	9.89	13.57	8.51	5.29	1.15	10.58	0.92	0.23	0.92	1.15
neuroblastoma cell line:NB-1	10539-107G8	14.03	12.53	8.04	7.67	2.06	3.74	3.37	0.19	1.87	2.06
neuroblastoma cell line:NBsusSR	10607-108F4	6.96	2.95	2.74	1.90	0.21	4.64	1.27	0.00	2.32	0.84
neuroblastoma cell line:NH-12	10555-107I6	10.06	9.32	3.35	3.17	0.37	7.45	2.05	0.00	1.12	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.15	9.01	8.54	9.01	0.24	6.88	1.19	0.00	4.03	1.19
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	21.06	5.23	3.33	6.34	0.63	3.80	0.95	0.00	2.53	3.01
neuroectodermal tumor cell line:TASK1	10774-110F9	13.48	5.03	2.42	11.07	0.00	1.81	1.01	0.40	1.21	3.82
neuroepithelioma cell line:SK-N-MC	10728-110A8	50.86	4.45	3.81	1.91	0.64	1.27	0.00	0.00	3.18	5.72
neurofibroma cell line:Hs 53.T	10729-110A9	24.49	9.85	7.45	2.40	4.26	1.60	0.80	0.53	1.06	2.13
neutrophil PMN, donor1	12133-128D9	14.87	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	26.21	2.20	4.23	12.18	1.18	5.92	0.85	0.00	1.18	1.86
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.80	10.41	14.41	3.20	0.80	0.80	2.40	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	12.50	7.05	7.69	3.85	3.21	2.24	1.28	0.32	1.28	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	7.62	3.68	4.73	3.15	3.15	1.84	1.58	0.00	1.58	0.26
nucleus accumbens, adult, pool1	10037-101F1	15.19	8.44	6.84	6.28	1.97	9.56	3.84	0.66	3.56	1.31
occipital cortex - adult, donor10196	10172-103C1	43.27	10.30	20.60	4.12	4.12	18.54	0.00	2.06	8.24	0.00
occipital cortex, adult, donor10252	10163-103B1	23.08	11.54	6.17	5.10	0.81	18.25	1.34	0.27	6.44	1.34
occipital cortex, newborn, donor10223	10355-105E4	11.65	8.37	4.37	5.46	0.73	6.55	0.73	0.36	1.82	0.36
occipital lobe, adult, donor1	10076-102A4	18.89	13.64	10.50	7.61	1.31	6.04	1.05	0.52	4.20	1.05
occipital lobe, fetal, donor1	10073-102A1	43.77	13.73	16.31	3.86	0.43	20.17	0.86	0.86	12.01	2.57
occipital pole, adult, pool1	10036-101E9	8.99	2.76	3.07	2.60	0.71	8.75	0.24	0.00	1.10	0.79
olfactory region, adult	10195-103E6	18.53	10.32	10.32	6.11	0.76	11.08	0.76	0.38	1.91	0.96
optic nerve, donor1	10277-104E7	32.02	16.01	12.01	0.00	0.00	8.00	0.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	21.19	6.26	5.13	7.18	1.25	7.63	10.37	0.00	2.05	1.94
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.18	7.14	3.98	4.26	0.00	1.79	0.69	0.00	0.69	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.83	16.76	10.33	5.59	2.03	3.39	2.37	0.17	1.35	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	5.08	2.54	1.62	2.31	0.35	1.50	1.04	0.00	0.58	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	26.46	6.17	5.88	2.35	4.41	3.53	0.00	0.00	1.18	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	59.80	47.65	39.24	3.74	14.02	22.42	0.93	0.93	1.87	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	20.99	6.36	3.39	5.09	1.27	1.48	0.85	0.00	2.12	3.82
ovary, adult, pool1	10020-101D2	10.31	30.31	23.93	7.51	0.87	5.50	0.09	0.44	1.83	1.57
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	59.40	30.61	26.40	7.70	4.58	2.93	1.28	3.67	2.93	6.42
pancreas, adult, donor1	10049-101G4	15.99	0.00	5.64	2.82	0.00	0.94	0.94	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	22.92	10.90	10.34	5.03	0.56	8.39	1.12	0.00	2.24	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	38.84	47.19	20.95	3.92	22.15	6.98	6.47	3.07	4.43	2.90
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	30.80	11.26	20.70	8.61	0.50	10.76	4.14	0.50	3.31	2.65
paracentral gyrus, adult, pool1	10035-101E8	14.92	7.14	4.30	7.32	1.46	8.33	0.55	0.18	2.65	0.55
parietal cortex, adult, donor10258	10373-105G4	19.82	5.87	7.34	3.67	2.20	11.74	1.47	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	33.86	6.58	14.11	6.58	0.94	11.29	0.94	0.00	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	24.51	9.98	8.27	4.85	1.71	21.95	0.86	0.00	3.99	0.00
parietal lobe, adult, pool1	10034-101E7	14.63	6.26	3.97	5.29	1.06	8.20	0.70	0.00	2.11	0.88
parietal lobe, fetal, donor1	10072-101I9	62.07	25.22	23.28	6.79	0.97	25.22	1.94	0.00	8.73	1.94
parietal lobe, newborn, donor10223	10356-105E5	12.71	7.10	4.49	4.86	2.99	12.71	1.50	0.75	0.37	0.37
parotid gland, adult	10199-103F1	9.25	6.78	12.95	6.78	0.00	5.55	0.00	0.00	1.23	1.23
penis, adult	10200-103F2	15.04	11.28	22.56	4.83	2.15	3.76	0.54	0.54	1.07	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	7.81	9.48	2.97	4.46	0.00	2.79	0.00	0.37	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	14.86	5.10	8.30	6.12	1.02	2.62	0.73	0.44	2.04	1.31
pineal gland - adult, donor10196	10179-103C8	45.15	10.32	15.48	1.94	0.65	14.19	0.00	0.00	2.58	1.94
pineal gland, adult, donor10252	10160-103A7	56.26	16.58	24.87	6.51	1.78	26.06	4.15	0.00	7.70	1.78
pineal gland, adult, donor10258	10377-105G8	31.35	12.54	9.41	5.64	1.25	22.57	0.63	0.00	3.14	0.63
pituitary gland - adult, donor10196	10180-103C9	60.71	28.33	34.40	9.11	6.07	9.11	23.27	1.01	11.13	3.04
pituitary gland, adult, donor10252	10162-103A9	81.30	51.60	51.08	9.90	5.21	16.68	29.19	2.08	14.07	8.34
pituitary gland, adult, donor10258	10378-105G9	51.07	21.28	18.73	7.66	1.70	8.51	5.96	0.00	7.66	3.40
placenta, adult, pool1	10021-101D3	9.25	3.33	4.19	4.62	0.65	7.42	0.54	0.22	0.97	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	15.89	0.93	1.19	3.31	1.59	4.50	0.93	0.40	1.06	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	31.75	18.52	21.48	6.38	0.93	4.36	0.31	0.16	2.33	1.71
pons, adult, pool1	10033-101E6	11.27	10.07	7.06	8.26	0.77	14.12	0.77	0.09	2.50	1.03
postcentral gyrus, adult, pool1	10032-101E5	8.72	4.10	4.36	3.66	0.26	7.24	0.09	0.09	1.39	1.22
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	2.09	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	7.57	14.13	10.49	4.52	1.46	1.02	7.14	0.58	0.58	0.87
prostate cancer cell line:PC-3	10439-106E7	29.04	36.12	25.23	9.08	4.17	8.17	0.54	1.45	3.27	3.09
prostate, adult, pool1	10022-101D4	15.87	25.39	33.10	6.53	1.81	5.80	0.73	0.09	1.45	1.18
putamen, adult, donor10196	10176-103C5	28.33	11.57	13.69	8.50	2.83	8.50	21.25	0.47	4.25	4.25
putamen, adult, donor10252	10152-102I8	27.45	3.92	7.84	0.00	1.96	5.88	1.96	0.00	3.92	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	46.99	12.02	7.65	4.37	4.37	15.30	2.19	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	18.36	6.04	4.83	7.25	1.21	7.73	3.87	0.48	1.21	0.48
putamen, newborn, donor10223	10365-105F5	32.24	10.50	6.75	9.75	4.50	9.75	3.00	0.00	1.50	3.00
rectal cancer cell line:TT1TKB	10469-106I1	14.84	9.31	6.40	4.65	0.29	1.75	1.45	0.00	1.16	0.58
rectum, fetal, donor1	10067-101I4	33.38	20.86	22.26	9.74	0.00	2.78	0.00	0.00	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	12.51	7.00	8.06	4.66	0.64	7.84	0.42	0.00	1.70	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	16.57	36.45	7.46	0.00	2.90	0.00	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	14.21	12.52	13.32	2.88	0.99	8.95	0.50	0.00	2.58	1.39
retinoblastoma cell line:Y79	10475-106I7	11.17	8.57	9.09	18.71	0.52	14.29	2.86	0.00	1.56	1.56
rhabdomyosarcoma cell line:KYM-1	10787-110H4	8.11	3.20	2.09	5.16	0.25	3.20	0.12	0.12	0.49	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	49.49	16.87	8.15	16.87	0.28	7.87	0.84	0.00	7.31	4.22
sacrococcigeal teratoma cell line:HTST	10695-109G2	45.47	11.37	9.85	3.03	2.27	3.79	0.00	0.00	3.79	3.79
salivary acinar cells, donor1	11771-123I7	11.17	6.31	5.02	3.72	0.49	1.29	0.97	0.16	1.13	1.13
salivary acinar cells, donor2	11772-123I8	12.12	5.51	7.44	2.89	0.28	2.62	0.55	0.28	1.24	0.69
salivary acinar cells, donor3	11773-123I9	27.14	5.96	5.96	0.66	0.00	10.59	0.00	0.00	3.97	2.65
salivary gland, adult, pool1	10093-102C3	9.72	2.86	4.00	0.57	0.00	9.72	0.00	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	13.41	7.67	7.08	8.18	1.43	5.82	0.25	0.17	1.35	0.59
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	18.10	9.40	6.47	7.76	1.29	6.00	0.94	0.35	2.70	1.53
seminal vesicle, adult	10201-103F3	22.75	16.40	19.58	3.70	0.53	11.64	0.53	0.53	2.12	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	17.49	6.32	6.32	3.89	2.92	6.80	2.92	0.49	1.94	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.26	3.27	3.52	1.26	0.75	1.76	0.00	0.00	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	8.03	5.02	6.02	1.00	3.01	4.01	1.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	6.85	0.94	0.94	4.84	0.00	4.84	0.67	0.00	1.21	1.07
signet ring carcinoma cell line:Kato III	10436-106E4	10.06	1.99	1.77	4.09	0.44	3.43	0.33	0.00	2.65	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	8.00	2.32	2.32	4.52	0.26	2.06	0.13	0.00	1.42	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	4.26	8.51	0.00	2.84	0.00	2.13	0.00	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	6.24	8.16	7.20	4.20	0.24	2.40	0.24	0.36	0.60	0.00
skeletal muscle, fetal, donor1	10066-101I3	11.06	8.04	7.04	4.02	1.01	2.01	0.00	0.00	2.01	0.00
skin, adult, donor1	10074-102A2	13.57	13.57	13.57	13.57	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	11.36	15.78	8.84	1.26	2.52	1.26	0.00	1.26	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	10.34	3.00	6.00	3.34	0.00	3.00	1.33	0.00	0.67	1.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.51	12.29	25.22	9.46	0.32	5.67	0.63	0.00	0.95	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	10.99	6.55	8.67	3.47	0.39	7.90	0.19	0.19	2.31	0.58
small cell lung carcinoma cell line:LK-2	10541-107H1	14.34	2.31	4.29	3.79	0.16	3.30	1.48	0.49	1.48	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	4.83	6.27	5.63	5.79	0.00	14.96	5.31	0.00	0.48	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	29.42	20.27	30.51	4.36	0.65	5.67	2.40	0.65	5.01	5.01
small intestine, adult, pool1	10024-101D6	15.05	7.17	7.17	8.48	0.96	5.26	1.67	0.00	1.55	0.84
small intestine, fetal, donor1	10064-101I1	16.46	2.95	5.16	4.42	0.98	3.93	0.25	0.00	1.23	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	18.98	12.31	9.75	3.59	0.51	3.08	3.08	0.00	3.08	1.03
smooth muscle, adult, pool1	10048-101G3	15.77	34.37	30.50	3.88	0.00	3.36	1.03	0.00	1.55	1.29
somatostatinoma cell line:QGP-1	10781-110G7	32.97	4.02	5.90	1.61	0.00	1.61	0.80	0.00	1.88	5.09
spinal cord - adult, donor10196	10181-103D1	23.40	19.04	20.19	7.11	0.69	7.57	0.23	0.23	3.44	0.92
spinal cord, adult, donor10252	10159-103A6	12.62	11.04	8.28	5.91	0.00	9.46	0.00	0.00	5.52	0.39
spinal cord, adult, donor10258	10369-105F9	35.28	3.46	4.84	3.46	0.00	13.14	0.00	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	31.10	17.69	12.20	5.49	1.22	3.66	0.61	0.61	1.83	1.22
spinal cord, newborn, donor10223	10359-105E8	28.47	11.94	9.64	4.59	0.46	15.15	0.00	0.00	1.38	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	22.10	3.73	4.63	4.63	2.69	1.79	0.30	0.90	1.64	1.19
spleen, adult, pool1	10025-101D7	18.06	3.96	9.36	10.24	1.76	7.38	2.20	0.11	1.87	1.10
spleen, fetal, pool1	10044-101F8	12.87	3.50	3.81	3.02	0.64	4.53	1.91	0.16	1.43	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	13.97	1.24	1.14	5.90	0.21	5.07	0.93	0.10	1.24	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	11.20	8.54	6.46	4.37	0.00	2.28	0.95	0.00	0.95	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	6.29	2.45	5.59	2.80	0.00	3.49	0.00	0.00	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.28	5.86	6.25	3.13	0.39	6.65	0.39	0.00	1.95	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	15.53	5.40	6.64	10.92	0.90	14.18	0.34	0.00	3.49	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.98	3.81	5.51	5.93	0.42	1.27	0.85	0.00	1.69	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	96.88	20.31	17.77	8.88	5.50	8.04	23.69	0.42	7.62	1.69
stomach, fetal, donor1	10062-101H8	59.81	8.54	14.95	6.41	1.07	5.34	1.07	0.00	0.00	3.20
submaxillary gland, adult	10202-103F4	18.23	3.99	8.55	2.85	1.14	10.25	0.00	0.57	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	54.27	0.00	0.00	54.27	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	18.28	10.39	8.72	2.91	0.42	7.48	0.00	0.21	2.49	0.21
substantia nigra, adult, donor10258	10371-105G2	24.83	4.66	4.14	1.55	0.00	10.86	1.03	0.00	2.07	0.00
substantia nigra, newborn, donor10223	10358-105E7	36.04	13.42	6.36	2.83	0.00	9.19	0.00	0.71	2.12	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	26.82	29.58	30.72	10.78	3.90	8.02	1.15	0.00	2.06	2.75
temporal lobe, adult, pool1	10031-101E4	7.38	4.75	3.14	4.15	0.59	6.61	0.34	0.08	1.86	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	49.15	20.66	15.67	5.70	0.00	22.08	2.14	0.71	8.55	9.97
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	25.49	11.43	8.35	5.71	0.88	29.01	0.44	0.88	2.64	1.76
tenocyte, donor1	11763-123H8	15.71	4.19	5.59	6.28	4.19	2.44	0.70	0.00	1.75	0.70
tenocyte, donor2	11765-123I1	21.36	5.34	9.54	2.29	9.92	1.91	1.14	0.76	1.14	1.91
tenocyte, donor3	11768-123I4	14.09	5.56	6.30	1.85	4.08	2.97	0.74	0.00	1.85	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	19.38	19.89	15.30	11.05	1.19	4.59	10.54	0.00	2.04	2.55
teratocarcinoma cell line:NCR-G1	10798-110I6	8.02	4.01	5.09	4.47	0.15	1.23	1.08	0.15	0.77	2.16
teratocarcinoma cell line:PA-1	10807-111A6	3.10	6.97	5.42	6.04	0.31	1.24	2.01	0.00	0.93	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.96	37.32	35.67	10.79	1.52	2.29	3.05	0.89	1.40	3.05
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	11.35	15.88	25.72	19.29	1.13	12.10	0.38	0.00	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.82	45.37	40.03	11.89	1.64	3.71	1.64	0.76	0.87	1.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	16.61	14.33	16.61	17.59	0.33	6.84	0.65	0.98	0.98	1.95
testis, adult, pool1	10026-101D8	21.37	41.88	30.06	7.62	3.11	7.19	16.86	1.93	2.36	2.47
testis, adult, pool2	10096-102C6	19.40	10.83	13.08	3.16	0.45	7.67	8.57	0.45	0.90	1.35
thalamus - adult, donor10196	10168-103B6	44.16	6.62	12.14	3.31	0.00	5.52	0.00	1.10	1.10	2.21
thalamus, adult, donor10252	10154-103A1	24.22	8.91	7.03	4.06	1.09	13.91	0.94	0.16	3.44	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	50.81	1.54	1.54	7.70	0.00	13.86	3.08	0.00	3.08	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	10.54	4.28	7.74	2.64	0.16	3.13	0.16	0.16	1.81	0.00
thalamus, newborn, donor10223	10366-105F6	13.23	4.03	5.75	6.33	2.30	9.78	0.58	0.00	1.73	0.58
throat, adult	10209-103G2	9.99	8.74	10.24	5.99	0.50	6.49	0.50	0.00	0.75	1.00
throat, fetal, donor1	10061-101H7	17.67	8.53	14.93	6.09	0.30	3.96	1.22	0.00	3.05	3.05
thymic carcinoma cell line:Ty-82	10803-111A2	7.75	8.35	7.75	6.56	0.20	5.56	0.40	0.00	0.79	0.60
thymus, adult, pool1	10027-101D9	26.94	9.84	14.02	9.84	4.77	7.36	1.49	0.70	3.08	6.66
thymus, fetal, pool1	10043-101F7	34.29	10.39	12.36	8.10	5.51	8.00	3.32	0.62	2.91	5.82
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.64	8.91	8.11	8.38	2.13	3.46	1.33	0.40	1.33	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	39.53	17.46	13.83	8.10	3.77	1.96	6.01	0.98	3.77	3.91
thyroid, adult, pool1	10028-101E1	12.22	9.52	12.78	4.57	1.21	8.12	0.75	0.28	1.49	0.47
thyroid, fetal, donor1	10060-101H6	21.88	5.80	11.60	5.27	0.53	3.95	0.00	0.26	3.16	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	9.24	21.56	0.00	0.00	3.08	0.00	0.00	9.24	0.00
tongue, adult	10203-103F5	6.28	6.28	10.93	3.26	0.47	5.12	0.47	0.23	0.93	0.23
tongue, fetal, donor1	10059-101H5	14.58	4.73	7.49	5.12	0.39	3.15	0.39	0.00	1.18	0.39
tonsil, adult, pool1	10047-101G2	16.83	1.90	3.61	2.80	1.30	5.01	1.30	0.10	2.10	2.20
trachea, adult, pool1	10029-101E2	14.23	6.79	9.65	5.40	1.72	6.54	0.65	0.25	1.96	0.57
trachea, fetal, donor1	10058-101H4	16.93	15.00	11.93	5.77	1.15	1.54	1.15	0.00	2.69	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	15.94	7.09	5.67	2.83	6.02	2.48	0.71	1.77	0.35	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	16.72	6.18	7.70	8.92	1.72	6.18	2.74	0.20	2.53	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	11.59	9.40	6.74	8.62	1.57	1.25	2.51	1.10	0.63	1.41
tridermal teratoma cell line:HGRT	10694-109G1	55.17	17.12	19.03	1.90	9.51	3.81	1.90	1.90	3.81	9.51
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	8.72	3.30	3.98	4.66	0.34	1.95	0.34	0.08	1.69	0.76
umbilical cord, fetal, donor1	10057-101H3	10.43	6.26	8.35	4.17	0.00	2.09	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	17.75	18.26	23.89	2.90	0.85	5.97	0.34	0.17	1.88	0.00
uterus, fetal, donor1	10055-101H1	30.20	22.52	18.94	5.63	2.56	5.12	0.51	0.00	3.58	5.12
vagina, adult	10204-103F6	11.63	14.22	19.39	3.88	0.00	7.11	0.00	0.00	1.29	0.00
vein, adult	10191-103E2	20.17	5.04	8.55	3.51	1.32	5.70	0.88	0.22	1.75	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	13.08	1.60	2.67	3.47	0.80	1.60	1.34	0.00	0.53	1.34